'hypoaldostéronisme'
(id=6084876 ; fe=hypoaldostéronisme ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=18009 creation date=2017-06-08 touchdate=2025-12-06 18:12:24.000)

≈ 847 relations sortantes hypoaldostéronisme -- r_associated #0: 359 / 1 -> médecine n1=hypoaldostéronisme | n2=médecine | rel=r_associated | relid=0 | w=359 hypoaldostéronisme -- r_associated #0: 212 / 0.591 -> processus pathologique n1=hypoaldostéronisme | n2=processus pathologique | rel=r_associated | relid=0 | w=212 hypoaldostéronisme -- r_associated #0: 211 / 0.588 -> en:hypoaldosteronism, hyporeninemic n1=hypoaldostéronisme | n2=en:hypoaldosteronism, hyporeninemic | rel=r_associated | relid=0 | w=211 hypoaldostéronisme -- r_associated #0: 199 / 0.554 -> infarctus de la surrénale n1=hypoaldostéronisme | n2=infarctus de la surrénale | rel=r_associated | relid=0 | w=199 hypoaldostéronisme -- r_associated #0: 196 / 0.546 -> syndrome de Waterhouse-Friderichsen n1=hypoaldostéronisme | n2=syndrome de Waterhouse-Friderichsen | rel=r_associated | relid=0 | w=196 hypoaldostéronisme -- r_associated #0: 191 / 0.532 -> insuffisance corticosurrénale n1=hypoaldostéronisme | n2=insuffisance corticosurrénale | rel=r_associated | relid=0 | w=191 hypoaldostéronisme -- r_associated #0: 187 / 0.521 -> hypoaldostéronisme hyporéninémique n1=hypoaldostéronisme | n2=hypoaldostéronisme hyporéninémique | rel=r_associated | relid=0 | w=187 hypoaldostéronisme -- r_associated #0: 185 / 0.515 -> hypoaldostéronismes n1=hypoaldostéronisme | n2=hypoaldostéronismes | rel=r_associated | relid=0 | w=185 hypoaldostéronisme -- r_associated #0: 180 / 0.501 -> hémorragie de la surrénale n1=hypoaldostéronisme | n2=hémorragie de la surrénale | rel=r_associated | relid=0 | w=180 hypoaldostéronisme -- r_associated #0: 164 / 0.457 -> en:hypoaldosteronemia n1=hypoaldostéronisme | n2=en:hypoaldosteronemia | rel=r_associated | relid=0 | w=164 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:'cytomegalic' cells (large, pale) in adrenal glands n1=hypoaldostéronisme | n2=en:'cytomegalic' cells (large, pale) in adrenal glands | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal 11-deoxy, 17-hydroxycorticosterone n1=hypoaldostéronisme | n2=en:abnormal 11-deoxy, 17-hydroxycorticosterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal 11-deoxycorticosterone n1=hypoaldostéronisme | n2=en:abnormal 11-deoxycorticosterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal 17-ketogenic steroids n1=hypoaldostéronisme | n2=en:abnormal 17-ketogenic steroids | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal adrenal cortical hormone n1=hypoaldostéronisme | n2=en:abnormal adrenal cortical hormone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal adrenocorticotropic hormone n1=hypoaldostéronisme | n2=en:abnormal adrenocorticotropic hormone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal androgen n1=hypoaldostéronisme | n2=en:abnormal androgen | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal corticotropin releasing factor n1=hypoaldostéronisme | n2=en:abnormal corticotropin releasing factor | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal cortisone n1=hypoaldostéronisme | n2=en:abnormal cortisone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal epinephrine n1=hypoaldostéronisme | n2=en:abnormal epinephrine | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal estradiol n1=hypoaldostéronisme | n2=en:abnormal estradiol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal estriol n1=hypoaldostéronisme | n2=en:abnormal estriol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal glucose tolerance n1=hypoaldostéronisme | n2=en:abnormal glucose tolerance | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal glucose tolerance test n1=hypoaldostéronisme | n2=en:abnormal glucose tolerance test | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal growth hormone (139250) response to stimulus n1=hypoaldostéronisme | n2=en:abnormal growth hormone (139250) response to stimulus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal human chorionic gonadotropin n1=hypoaldostéronisme | n2=en:abnormal human chorionic gonadotropin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal human growth hormone n1=hypoaldostéronisme | n2=en:abnormal human growth hormone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal melanocyte stimulating hormone n1=hypoaldostéronisme | n2=en:abnormal melanocyte stimulating hormone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal oxytocin n1=hypoaldostéronisme | n2=en:abnormal oxytocin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal pituitary gonadotropin n1=hypoaldostéronisme | n2=en:abnormal pituitary gonadotropin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal polypeptide hormone n1=hypoaldostéronisme | n2=en:abnormal polypeptide hormone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal pregnanediol n1=hypoaldostéronisme | n2=en:abnormal pregnanediol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal progesterone n1=hypoaldostéronisme | n2=en:abnormal progesterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal prolactin n1=hypoaldostéronisme | n2=en:abnormal prolactin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal protein hormone n1=hypoaldostéronisme | n2=en:abnormal protein hormone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal serotonin n1=hypoaldostéronisme | n2=en:abnormal serotonin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal testosterone n1=hypoaldostéronisme | n2=en:abnormal testosterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal thyroxine n1=hypoaldostéronisme | n2=en:abnormal thyroxine | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal triiodothyronine n1=hypoaldostéronisme | n2=en:abnormal triiodothyronine | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormal vanillylmandelic acid n1=hypoaldostéronisme | n2=en:abnormal vanillylmandelic acid | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:abnormality of cortisol-binding globulin n1=hypoaldostéronisme | n2=en:abnormality of cortisol-binding globulin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:absent dehydroepiandrosterone-sulphate, even after acth stimulation n1=hypoaldostéronisme | n2=en:absent dehydroepiandrosterone-sulphate, even after acth stimulation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:absent or low response to gonadotropin-releasing hormone stimulation n1=hypoaldostéronisme | n2=en:absent or low response to gonadotropin-releasing hormone stimulation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:absent or minimal increase in pregnanetriol after hcg stimulation n1=hypoaldostéronisme | n2=en:absent or minimal increase in pregnanetriol after hcg stimulation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:acquired porphyria n1=hypoaldostéronisme | n2=en:acquired porphyria | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:acral overgrowth n1=hypoaldostéronisme | n2=en:acral overgrowth | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:acromegaloid features n1=hypoaldostéronisme | n2=en:acromegaloid features | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:addison's disease n1=hypoaldostéronisme | n2=en:addison's disease | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal androgen deficiency n1=hypoaldostéronisme | n2=en:adrenal androgen deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal atrophy n1=hypoaldostéronisme | n2=en:adrenal atrophy | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal calcification n1=hypoaldostéronisme | n2=en:adrenal calcification | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal cortex diseases n1=hypoaldostéronisme | n2=en:adrenal cortex diseases | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal cortical hypofunction n1=hypoaldostéronisme | n2=en:adrenal cortical hypofunction | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal cyst n1=hypoaldostéronisme | n2=en:adrenal cyst | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal failure (in some patients) n1=hypoaldostéronisme | n2=en:adrenal failure (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal gland cytomegaly n1=hypoaldostéronisme | n2=en:adrenal gland cytomegaly | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal gland disorder n1=hypoaldostéronisme | n2=en:adrenal gland disorder | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal gland dysgenesis n1=hypoaldostéronisme | n2=en:adrenal gland dysgenesis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal gland hyperplasia n1=hypoaldostéronisme | n2=en:adrenal gland hyperplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal gland tuberculosis n1=hypoaldostéronisme | n2=en:adrenal gland tuberculosis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal hemangiomas n1=hypoaldostéronisme | n2=en:adrenal hemangiomas | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal hyperplasia n1=hypoaldostéronisme | n2=en:adrenal hyperplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal hyperplasia, bilateral n1=hypoaldostéronisme | n2=en:adrenal hyperplasia, bilateral | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal hypoplasia n1=hypoaldostéronisme | n2=en:adrenal hypoplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal insufficiency, congenital (300200) in 'complex' form n1=hypoaldostéronisme | n2=en:adrenal insufficiency, congenital (300200) in 'complex' form | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal medullary insufficiency n1=hypoaldostéronisme | n2=en:adrenal medullary insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenal necrosis n1=hypoaldostéronisme | n2=en:adrenal necrosis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenocortical cytomegaly n1=hypoaldostéronisme | n2=en:adrenocortical cytomegaly | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenocortical hypofunction, chronic primary congenital n1=hypoaldostéronisme | n2=en:adrenocortical hypofunction, chronic primary congenital | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenocortical insufficiency n1=hypoaldostéronisme | n2=en:adrenocortical insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency n1=hypoaldostéronisme | n2=en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenocorticotropic hormone deficiency n1=hypoaldostéronisme | n2=en:adrenocorticotropic hormone deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenocorticotropin deficiency n1=hypoaldostéronisme | n2=en:adrenocorticotropin deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:adrenogenital syndrome n1=hypoaldostéronisme | n2=en:adrenogenital syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:age at natural menopause qtl n1=hypoaldostéronisme | n2=en:age at natural menopause qtl | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:alcohol-induced pseudo-cushing's syndrome n1=hypoaldostéronisme | n2=en:alcohol-induced pseudo-cushing's syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:aldosterone n1=hypoaldostéronisme | n2=en:aldosterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:aldosterone disorder n1=hypoaldostéronisme | n2=en:aldosterone disorder | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:aldosterone synthase deficiency n1=hypoaldostéronisme | n2=en:aldosterone synthase deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:androgen excess n1=hypoaldostéronisme | n2=en:androgen excess | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:androgen levels normal n1=hypoaldostéronisme | n2=en:androgen levels normal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:anterior pituitary enlargement n1=hypoaldostéronisme | n2=en:anterior pituitary enlargement | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:anterior pituitary hypoplasia n1=hypoaldostéronisme | n2=en:anterior pituitary hypoplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:autoimmune adrenal insufficiency n1=hypoaldostéronisme | n2=en:autoimmune adrenal insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:autoimmune primary adrenal insufficiency n1=hypoaldostéronisme | n2=en:autoimmune primary adrenal insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:autoimmune thyroiditis n1=hypoaldostéronisme | n2=en:autoimmune thyroiditis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:baseline pregnanediol and pregnanetriol normal n1=hypoaldostéronisme | n2=en:baseline pregnanediol and pregnanetriol normal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:brain diseases, metabolic n1=hypoaldostéronisme | n2=en:brain diseases, metabolic | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:c-cell hyperplasia n1=hypoaldostéronisme | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:catabolic state n1=hypoaldostéronisme | n2=en:catabolic state | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:central hyperthyroidism n1=hypoaldostéronisme | n2=en:central hyperthyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:central hypothyroidism, borderline n1=hypoaldostéronisme | n2=en:central hypothyroidism, borderline | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:cervical neuroendocrine carcinoma n1=hypoaldostéronisme | n2=en:cervical neuroendocrine carcinoma | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:citrate toxicity n1=hypoaldostéronisme | n2=en:citrate toxicity | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:compensated hypothyroidism n1=hypoaldostéronisme | n2=en:compensated hypothyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:complication aspects n1=hypoaldostéronisme | n2=en:complication aspects | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:congenital hypoparathyroidism n1=hypoaldostéronisme | n2=en:congenital hypoparathyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:congenital hypoplasia of thymus n1=hypoaldostéronisme | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:congenital hypothyroidism n1=hypoaldostéronisme | n2=en:congenital hypothyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:congenital mesh qualifier n1=hypoaldostéronisme | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:corticosterone methyl oxidase type ii deficiency n1=hypoaldostéronisme | n2=en:corticosterone methyl oxidase type ii deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:corticotropin-releasing hormone deficiency n1=hypoaldostéronisme | n2=en:corticotropin-releasing hormone deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:cortisol deficiency n1=hypoaldostéronisme | n2=en:cortisol deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:cortisol insufficiency n1=hypoaldostéronisme | n2=en:cortisol insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:crystal arthropathy n1=hypoaldostéronisme | n2=en:crystal arthropathy | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:cushing disease n1=hypoaldostéronisme | n2=en:cushing disease | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:cushingoid n1=hypoaldostéronisme | n2=en:cushingoid | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:cushingoid appearance (2 patients) n1=hypoaldostéronisme | n2=en:cushingoid appearance (2 patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:decreased circulating renin level n1=hypoaldostéronisme | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:decreased fertility in males n1=hypoaldostéronisme | n2=en:decreased fertility in males | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:decreased growth hormone (in some patients) n1=hypoaldostéronisme | n2=en:decreased growth hormone (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:decreased testosterone (in some patients) n1=hypoaldostéronisme | n2=en:decreased testosterone (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:decreased testosterone in males n1=hypoaldostéronisme | n2=en:decreased testosterone in males | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:decreased thyroxine level n1=hypoaldostéronisme | n2=en:decreased thyroxine level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:defective dht formation n1=hypoaldostéronisme | n2=en:defective dht formation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:deficient growth hormone response to insulin, arginine, or levodopa n1=hypoaldostéronisme | n2=en:deficient growth hormone response to insulin, arginine, or levodopa | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:delayed conversion of oral cortisone acetate to plasma cortisol n1=hypoaldostéronisme | n2=en:delayed conversion of oral cortisone acetate to plasma cortisol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:delayed onset of puberty n1=hypoaldostéronisme | n2=en:delayed onset of puberty | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:delayed pubertal development (rare) n1=hypoaldostéronisme | n2=en:delayed pubertal development (rare) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:delayed puberty (in some patients) n1=hypoaldostéronisme | n2=en:delayed puberty (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:delayed secondary sexual characteristics in males n1=hypoaldostéronisme | n2=en:delayed secondary sexual characteristics in males | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:delayed testosterone increase at puberty n1=hypoaldostéronisme | n2=en:delayed testosterone increase at puberty | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes (may develop later in life) n1=hypoaldostéronisme | n2=en:diabetes (may develop later in life) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes insipidus n1=hypoaldostéronisme | n2=en:diabetes insipidus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes insipidus (in some patients) n1=hypoaldostéronisme | n2=en:diabetes insipidus (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes mellitus n1=hypoaldostéronisme | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes mellitus (1 patient) n1=hypoaldostéronisme | n2=en:diabetes mellitus (1 patient) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes mellitus (less common) n1=hypoaldostéronisme | n2=en:diabetes mellitus (less common) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes mellitus (rare) n1=hypoaldostéronisme | n2=en:diabetes mellitus (rare) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes mellitus, infantile n1=hypoaldostéronisme | n2=en:diabetes mellitus, infantile | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes mellitus, insulin-dependent, late onset (uncommon) n1=hypoaldostéronisme | n2=en:diabetes mellitus, insulin-dependent, late onset (uncommon) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes mellitus, susceptibility to n1=hypoaldostéronisme | n2=en:diabetes mellitus, susceptibility to | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetes, early-onset (in some patients) n1=hypoaldostéronisme | n2=en:diabetes, early-onset (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diabetic ketoacidosis n1=hypoaldostéronisme | n2=en:diabetic ketoacidosis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:diagnosis aspect n1=hypoaldostéronisme | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:disorder of cortisol-cortisone shuttle n1=hypoaldostéronisme | n2=en:disorder of cortisol-cortisone shuttle | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:disorders of bilirubin excretion n1=hypoaldostéronisme | n2=en:disorders of bilirubin excretion | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:drug-induced adrenocortical insufficiency n1=hypoaldostéronisme | n2=en:drug-induced adrenocortical insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:dysfunction adrenal n1=hypoaldostéronisme | n2=en:dysfunction adrenal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:dysfunction syndromes, hypothalamic n1=hypoaldostéronisme | n2=en:dysfunction syndromes, hypothalamic | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:early-onset type ii diabetes (rare) n1=hypoaldostéronisme | n2=en:early-onset type ii diabetes (rare) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:ectopic hyperthyroidism n1=hypoaldostéronisme | n2=en:ectopic hyperthyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:ectopic posterior pituitary n1=hypoaldostéronisme | n2=en:ectopic posterior pituitary | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated 18-hydroxycortisol n1=hypoaldostéronisme | n2=en:elevated 18-hydroxycortisol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated 18-oxocortisol n1=hypoaldostéronisme | n2=en:elevated 18-oxocortisol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated fasting glucose n1=hypoaldostéronisme | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated follicle stimulating hormone (fsh) n1=hypoaldostéronisme | n2=en:elevated follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated follicle-stimulating hormone (fsh) level n1=hypoaldostéronisme | n2=en:elevated follicle-stimulating hormone (fsh) level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated follicle-stimulating hormone level n1=hypoaldostéronisme | n2=en:elevated follicle-stimulating hormone level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated growth hormone (gh) levels n1=hypoaldostéronisme | n2=en:elevated growth hormone (gh) levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated luteinizing hormone (lh) level n1=hypoaldostéronisme | n2=en:elevated luteinizing hormone (lh) level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated prepubertal levels of estradiol n1=hypoaldostéronisme | n2=en:elevated prepubertal levels of estradiol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated prepubertal levels of testosterone n1=hypoaldostéronisme | n2=en:elevated prepubertal levels of testosterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated serum follicle-stimulating hormone (in male and female patients) n1=hypoaldostéronisme | n2=en:elevated serum follicle-stimulating hormone (in male and female patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated serum luteinizing hormone (in male and female patients) n1=hypoaldostéronisme | n2=en:elevated serum luteinizing hormone (in male and female patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:elevated urinary gonadotropins n1=hypoaldostéronisme | n2=en:elevated urinary gonadotropins | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:embryologic n1=hypoaldostéronisme | n2=en:embryologic | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:endocrine features n1=hypoaldostéronisme | n2=en:endocrine features | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:endocrine hypertension n1=hypoaldostéronisme | n2=en:endocrine hypertension | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:endocrine pancreatic adenoma n1=hypoaldostéronisme | n2=en:endocrine pancreatic adenoma | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:enhanced insulin sensitivity n1=hypoaldostéronisme | n2=en:enhanced insulin sensitivity | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:enlarged adrenal gland n1=hypoaldostéronisme | n2=en:enlarged adrenal gland | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:enzyme abnormality (nos) n1=hypoaldostéronisme | n2=en:enzyme abnormality (nos) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:enzymology n1=hypoaldostéronisme | n2=en:enzymology | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:epidemiologic n1=hypoaldostéronisme | n2=en:epidemiologic | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:estradiol undetectable n1=hypoaldostéronisme | n2=en:estradiol undetectable | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:euthyroid (compensated hypothyroidism) n1=hypoaldostéronisme | n2=en:euthyroid (compensated hypothyroidism) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:euthyroid (finding) n1=hypoaldostéronisme | n2=en:euthyroid (finding) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:euthyroidism n1=hypoaldostéronisme | n2=en:euthyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:female infertility n1=hypoaldostéronisme | n2=en:female infertility | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:follicle stimulating hormone, increased n1=hypoaldostéronisme | n2=en:follicle stimulating hormone, increased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:gastrin-producing neuroendocrine tumor n1=hypoaldostéronisme | n2=en:gastrin-producing neuroendocrine tumor | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:glucagonoma syndrome n1=hypoaldostéronisme | n2=en:glucagonoma syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:glucocorticoid insufficiency n1=hypoaldostéronisme | n2=en:glucocorticoid insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:goiter n1=hypoaldostéronisme | n2=en:goiter | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:goiter may occur n1=hypoaldostéronisme | n2=en:goiter may occur | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:gonadotrophin increased n1=hypoaldostéronisme | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:gonadotrophin levels low n1=hypoaldostéronisme | n2=en:gonadotrophin levels low | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients) n1=hypoaldostéronisme | n2=en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:growth hormone deficiency (reported in 1 patient) n1=hypoaldostéronisme | n2=en:growth hormone deficiency (reported in 1 patient) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hashimoto thyroiditis n1=hypoaldostéronisme | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hereditary adrenal unresponsiveness to corticotropin n1=hypoaldostéronisme | n2=en:hereditary adrenal unresponsiveness to corticotropin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:high absolute level of cortisone metabolites n1=hypoaldostéronisme | n2=en:high absolute level of cortisone metabolites | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:high follicle-stimulating hormone levels n1=hypoaldostéronisme | n2=en:high follicle-stimulating hormone levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:high serum leptin levels (rare) n1=hypoaldostéronisme | n2=en:high serum leptin levels (rare) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:high to high-normal cortisol secretion rate n1=hypoaldostéronisme | n2=en:high to high-normal cortisol secretion rate | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:historical aspects qualifier n1=hypoaldostéronisme | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperactive renin-angiotensin system n1=hypoaldostéronisme | n2=en:hyperactive renin-angiotensin system | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperamylasemia n1=hypoaldostéronisme | n2=en:hyperamylasemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperandrogenemia n1=hypoaldostéronisme | n2=en:hyperandrogenemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypercatabolism n1=hypoaldostéronisme | n2=en:hypercatabolism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypercortisolemia n1=hypoaldostéronisme | n2=en:hypercortisolemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypercortisolism, mild (in some patients) n1=hypoaldostéronisme | n2=en:hypercortisolism, mild (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypercreatinaemia n1=hypoaldostéronisme | n2=en:hypercreatinaemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypercreatininaemia n1=hypoaldostéronisme | n2=en:hypercreatininaemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperestrogenism n1=hypoaldostéronisme | n2=en:hyperestrogenism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperglycemia, insulin-responsive, episodic n1=hypoaldostéronisme | n2=en:hyperglycemia, insulin-responsive, episodic | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypergonadotrophic hypogonadism (in females in adolescence) n1=hypoaldostéronisme | n2=en:hypergonadotrophic hypogonadism (in females in adolescence) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypergonadotropic hypogonadism (hcs) n1=hypoaldostéronisme | n2=en:hypergonadotropic hypogonadism (hcs) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypergonadotropic hypogonadism (rare) n1=hypoaldostéronisme | n2=en:hypergonadotropic hypogonadism (rare) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperinsulinemia n1=hypoaldostéronisme | n2=en:hyperinsulinemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperinsulinemic hypoglycemia n1=hypoaldostéronisme | n2=en:hyperinsulinemic hypoglycemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperinsulinemic hypoglycemia (in some patients) n1=hypoaldostéronisme | n2=en:hyperinsulinemic hypoglycemia (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperkalemic mineralocorticoid resistance n1=hypoaldostéronisme | n2=en:hyperkalemic mineralocorticoid resistance | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypernatremia n1=hypoaldostéronisme | n2=en:hypernatremia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperphosphatasaemia n1=hypoaldostéronisme | n2=en:hyperphosphatasaemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperprogesteronism n1=hypoaldostéronisme | n2=en:hyperprogesteronism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperreninemic hypoaldosteronism n1=hypoaldostéronisme | n2=en:hyperreninemic hypoaldosteronism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypertension n1=hypoaldostéronisme | n2=en:hypertension | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyperthyroidism n1=hypoaldostéronisme | n2=en:hyperthyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypocalcemia n1=hypoaldostéronisme | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypocalcemia, mild or severe n1=hypoaldostéronisme | n2=en:hypocalcemia, mild or severe | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypocortisolemia n1=hypoaldostéronisme | n2=en:hypocortisolemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypoglycemia n1=hypoaldostéronisme | n2=en:hypoglycemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypogonadaism n1=hypoaldostéronisme | n2=en:hypogonadaism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypogonadism n1=hypoaldostéronisme | n2=en:hypogonadism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypogonadism (1 patient) n1=hypoaldostéronisme | n2=en:hypogonadism (1 patient) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypogonadism (reported in 1 patient) n1=hypoaldostéronisme | n2=en:hypogonadism (reported in 1 patient) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypogonadotropic hypogonadism n1=hypoaldostéronisme | n2=en:hypogonadotropic hypogonadism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypogonadotropic hypogonadism (in some females) n1=hypoaldostéronisme | n2=en:hypogonadotropic hypogonadism (in some females) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypogondotropic hypogonadism (1 patient) n1=hypoaldostéronisme | n2=en:hypogondotropic hypogonadism (1 patient) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypoinsulinaemia (disorder) n1=hypoaldostéronisme | n2=en:hypoinsulinaemia (disorder) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypokalemia (rare) n1=hypoaldostéronisme | n2=en:hypokalemia (rare) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypometabolism n1=hypoaldostéronisme | n2=en:hypometabolism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyponatremic mineralocorticoid resistance due to mineralocorticoid receptor defect n1=hypoaldostéronisme | n2=en:hyponatremic mineralocorticoid resistance due to mineralocorticoid receptor defect | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hyponatremic mineralocorticoid resistance due to urinary tract infection n1=hypoaldostéronisme | n2=en:hyponatremic mineralocorticoid resistance due to urinary tract infection | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypoparathyroidism n1=hypoaldostéronisme | n2=en:hypoparathyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypophosphatemic vitamin d-resistant rickets (in some) n1=hypoaldostéronisme | n2=en:hypophosphatemic vitamin d-resistant rickets (in some) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypoplasia of the thyroid gland in some patients n1=hypoaldostéronisme | n2=en:hypoplasia of the thyroid gland in some patients | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypoplastic pituitary gland n1=hypoaldostéronisme | n2=en:hypoplastic pituitary gland | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypoprogesteronism n1=hypoaldostéronisme | n2=en:hypoprogesteronism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothalamic and/or pituitary defect n1=hypoaldostéronisme | n2=en:hypothalamic and/or pituitary defect | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothalamic hypogonadism n1=hypoaldostéronisme | n2=en:hypothalamic hypogonadism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothalamic insufficiency n1=hypoaldostéronisme | n2=en:hypothalamic insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidic goitre n1=hypoaldostéronisme | n2=en:hypothyroidic goitre | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism n1=hypoaldostéronisme | n2=en:hypothyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism (20% of adults) n1=hypoaldostéronisme | n2=en:hypothyroidism (20% of adults) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism (30% patients) n1=hypoaldostéronisme | n2=en:hypothyroidism (30% patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism (in 1 of 3 siblings) n1=hypoaldostéronisme | n2=en:hypothyroidism (in 1 of 3 siblings) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism (in 2/4 patients) n1=hypoaldostéronisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism (in some patients) n1=hypoaldostéronisme | n2=en:hypothyroidism (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism (less common) n1=hypoaldostéronisme | n2=en:hypothyroidism (less common) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism (rare) n1=hypoaldostéronisme | n2=en:hypothyroidism (rare) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism, autoimmune n1=hypoaldostéronisme | n2=en:hypothyroidism, autoimmune | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:hypothyroidism, congenital (1 patient) n1=hypoaldostéronisme | n2=en:hypothyroidism, congenital (1 patient) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:iatrogenic adrenal insufficiency n1=hypoaldostéronisme | n2=en:iatrogenic adrenal insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:impaired glucose tolerance (in male patient) n1=hypoaldostéronisme | n2=en:impaired glucose tolerance (in male patient) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:impaired processing of proopiomelanocortin (pomc, 176830) n1=hypoaldostéronisme | n2=en:impaired processing of proopiomelanocortin (pomc, 176830) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:impaired temperature regulation n1=hypoaldostéronisme | n2=en:impaired temperature regulation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:in blood n1=hypoaldostéronisme | n2=en:in blood | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:in cerebrospinal fluid n1=hypoaldostéronisme | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increase in pregnanediol and pregnanetriol after acth stimulation n1=hypoaldostéronisme | n2=en:increase in pregnanediol and pregnanetriol after acth stimulation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased circulating renin level n1=hypoaldostéronisme | n2=en:increased circulating renin level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased cortisol excretion rate n1=hypoaldostéronisme | n2=en:increased cortisol excretion rate | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased gonadotropin levels (in female patients) n1=hypoaldostéronisme | n2=en:increased gonadotropin levels (in female patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased incidence of fibrocalculus pancreatic diabetes (fcpd) n1=hypoaldostéronisme | n2=en:increased incidence of fibrocalculus pancreatic diabetes (fcpd) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased prolactin level n1=hypoaldostéronisme | n2=en:increased prolactin level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased serum gonadotropins n1=hypoaldostéronisme | n2=en:increased serum gonadotropins | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased serum pth, mild n1=hypoaldostéronisme | n2=en:increased serum pth, mild | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased serum tsh (2 patients) n1=hypoaldostéronisme | n2=en:increased serum tsh (2 patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased sweating at early age n1=hypoaldostéronisme | n2=en:increased sweating at early age | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:increased testosterone n1=hypoaldostéronisme | n2=en:increased testosterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insensitivity to growth hormone therapy n1=hypoaldostéronisme | n2=en:insensitivity to growth hormone therapy | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insulin deficiency (may develop later in life) n1=hypoaldostéronisme | n2=en:insulin deficiency (may develop later in life) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insulin growth factor i deficiency n1=hypoaldostéronisme | n2=en:insulin growth factor i deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insulin growth factor i resistance n1=hypoaldostéronisme | n2=en:insulin growth factor i resistance | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insulin insensitivity n1=hypoaldostéronisme | n2=en:insulin insensitivity | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insulin-dependent but ketosis-resistant diabetes n1=hypoaldostéronisme | n2=en:insulin-dependent but ketosis-resistant diabetes | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insulin-dependent diabetes mellitus (onset in infancy) n1=hypoaldostéronisme | n2=en:insulin-dependent diabetes mellitus (onset in infancy) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:insulin-resistant diabetes mellitus at puberty n1=hypoaldostéronisme | n2=en:insulin-resistant diabetes mellitus at puberty | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:intermittent severe hypoglycemia n1=hypoaldostéronisme | n2=en:intermittent severe hypoglycemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:intermittent thrombocytopenia n1=hypoaldostéronisme | n2=en:intermittent thrombocytopenia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:ipsilateral adrenal gland hypoplasia n1=hypoaldostéronisme | n2=en:ipsilateral adrenal gland hypoplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:ipsilateral thyroid gland hypoplasia n1=hypoaldostéronisme | n2=en:ipsilateral thyroid gland hypoplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:isolated follicle stimulating hormone deficiency n1=hypoaldostéronisme | n2=en:isolated follicle stimulating hormone deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:lack of growth hormone (gh) response to stimulation n1=hypoaldostéronisme | n2=en:lack of growth hormone (gh) response to stimulation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:lack of lh pulsatility n1=hypoaldostéronisme | n2=en:lack of lh pulsatility | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:lack of secondary sex characteristics n1=hypoaldostéronisme | n2=en:lack of secondary sex characteristics | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:lack of secondary sexual characteristics (in 1 family) n1=hypoaldostéronisme | n2=en:lack of secondary sexual characteristics (in 1 family) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:lh level normal n1=hypoaldostéronisme | n2=en:lh level normal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:lingual thyroid n1=hypoaldostéronisme | n2=en:lingual thyroid | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low acth n1=hypoaldostéronisme | n2=en:low acth | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low adrenocorticotropic hormone (acth) n1=hypoaldostéronisme | n2=en:low adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low anti-mullerian hormone (amh) level n1=hypoaldostéronisme | n2=en:low anti-mullerian hormone (amh) level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low cortols-to-cortolone ratio n1=hypoaldostéronisme | n2=en:low cortols-to-cortolone ratio | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low estrogen and progesterone n1=hypoaldostéronisme | n2=en:low estrogen and progesterone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low follicle-stimulating hormone (fsh) n1=hypoaldostéronisme | n2=en:low follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low follicle-stimulating hormone levels n1=hypoaldostéronisme | n2=en:low follicle-stimulating hormone levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low free-t4 levels n1=hypoaldostéronisme | n2=en:low free-t4 levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low gonadotropins (secondary hypogonadism) n1=hypoaldostéronisme | n2=en:low gonadotropins (secondary hypogonadism) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low igf1 and igfbp3 n1=hypoaldostéronisme | n2=en:low igf1 and igfbp3 | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low inhibin b level n1=hypoaldostéronisme | n2=en:low inhibin b level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low insulin-like growth factor-i (igf1 147440) levels n1=hypoaldostéronisme | n2=en:low insulin-like growth factor-i (igf1 147440) levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low luteinizing hormone (lh) n1=hypoaldostéronisme | n2=en:low luteinizing hormone (lh) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low luteinizing hormone levels n1=hypoaldostéronisme | n2=en:low luteinizing hormone levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low or absent growth hormone (in some patients) n1=hypoaldostéronisme | n2=en:low or absent growth hormone (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low or absent prolactin n1=hypoaldostéronisme | n2=en:low or absent prolactin | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low or absent thyroid-stimulating hormone n1=hypoaldostéronisme | n2=en:low or absent thyroid-stimulating hormone | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low or normal serum gonadotropins n1=hypoaldostéronisme | n2=en:low or normal serum gonadotropins | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low prolactin (prl) levels (in some patients) n1=hypoaldostéronisme | n2=en:low prolactin (prl) levels (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low serum estradiol n1=hypoaldostéronisme | n2=en:low serum estradiol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low serum estradiol levels n1=hypoaldostéronisme | n2=en:low serum estradiol levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low sex hormone-binding globulin levels n1=hypoaldostéronisme | n2=en:low sex hormone-binding globulin levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low testosterone levels n1=hypoaldostéronisme | n2=en:low testosterone levels | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio n1=hypoaldostéronisme | n2=en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low to normal absolute level of cortisol metabolites n1=hypoaldostéronisme | n2=en:low to normal absolute level of cortisol metabolites | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low to normal serum gonadotropins n1=hypoaldostéronisme | n2=en:low to normal serum gonadotropins | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low to normal serum lh low to normal serum fsh n1=hypoaldostéronisme | n2=en:low to normal serum lh low to normal serum fsh | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low to undetectable insulin levels in the presence of hyperglycemia n1=hypoaldostéronisme | n2=en:low to undetectable insulin levels in the presence of hyperglycemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:low urinary estrogens n1=hypoaldostéronisme | n2=en:low urinary estrogens | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:luteinizing hormone levels elevated n1=hypoaldostéronisme | n2=en:luteinizing hormone levels elevated | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:macronodular adrenal hyperplasia n1=hypoaldostéronisme | n2=en:macronodular adrenal hyperplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:marine lenhart syndrome n1=hypoaldostéronisme | n2=en:marine lenhart syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:masculinization at puberty n1=hypoaldostéronisme | n2=en:masculinization at puberty | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:maturity-onset diabetes of the young n1=hypoaldostéronisme | n2=en:maturity-onset diabetes of the young | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:metabolic aspects n1=hypoaldostéronisme | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:metabolic disorder n1=hypoaldostéronisme | n2=en:metabolic disorder | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:metabolic disorders nec n1=hypoaldostéronisme | n2=en:metabolic disorders nec | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:metabolic syndrome n1=hypoaldostéronisme | n2=en:metabolic syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:mineralocorticoid deficiency n1=hypoaldostéronisme | n2=en:mineralocorticoid deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:mineralocorticoid insufficiency n1=hypoaldostéronisme | n2=en:mineralocorticoid insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:mineralocorticoid insufficiency (in 15%) n1=hypoaldostéronisme | n2=en:mineralocorticoid insufficiency (in 15%) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:modestly low estradiol n1=hypoaldostéronisme | n2=en:modestly low estradiol | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:multinodular goiter n1=hypoaldostéronisme | n2=en:multinodular goiter | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:multiple hormone resistance n1=hypoaldostéronisme | n2=en:multiple hormone resistance | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:necrosis adrenal cortex n1=hypoaldostéronisme | n2=en:necrosis adrenal cortex | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:neonatal diabetes mellitus n1=hypoaldostéronisme | n2=en:neonatal diabetes mellitus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:neonatal hyperbilirubinemia n1=hypoaldostéronisme | n2=en:neonatal hyperbilirubinemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:neonatal hypocalcemia, rare n1=hypoaldostéronisme | n2=en:neonatal hypocalcemia, rare | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:neonatal hypoglycemia n1=hypoaldostéronisme | n2=en:neonatal hypoglycemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:neonatal hypoparathyroidism n1=hypoaldostéronisme | n2=en:neonatal hypoparathyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:neonatal insulin-dependent diabetes mellitus n1=hypoaldostéronisme | n2=en:neonatal insulin-dependent diabetes mellitus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:neurogenic diabetes insipidus n1=hypoaldostéronisme | n2=en:neurogenic diabetes insipidus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:no adrenal insufficiency n1=hypoaldostéronisme | n2=en:no adrenal insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:no breast development or menstruation at puberty n1=hypoaldostéronisme | n2=en:no breast development or menstruation at puberty | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:no goiter n1=hypoaldostéronisme | n2=en:no goiter | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:no growth response to exogenous growth hormone (gh, 139250) n1=hypoaldostéronisme | n2=en:no growth response to exogenous growth hormone (gh, 139250) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:no hormone resistance n1=hypoaldostéronisme | n2=en:no hormone resistance | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:no increase in testosterone after hcg or acth stimulation n1=hypoaldostéronisme | n2=en:no increase in testosterone after hcg or acth stimulation | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:no insulin-dependent diabetes mellitus n1=hypoaldostéronisme | n2=en:no insulin-dependent diabetes mellitus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:non-neoplastic adrenal gland disorder n1=hypoaldostéronisme | n2=en:non-neoplastic adrenal gland disorder | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:nonautoimmune insulin-dependent diabetes in second decade of life n1=hypoaldostéronisme | n2=en:nonautoimmune insulin-dependent diabetes in second decade of life | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal adrenal function n1=hypoaldostéronisme | n2=en:normal adrenal function | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal female secondary sexual characteristics n1=hypoaldostéronisme | n2=en:normal female secondary sexual characteristics | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal growth hormone response to provocative testing n1=hypoaldostéronisme | n2=en:normal growth hormone response to provocative testing | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal or mildly elevated serum phosphate n1=hypoaldostéronisme | n2=en:normal or mildly elevated serum phosphate | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal pituitary function n1=hypoaldostéronisme | n2=en:normal pituitary function | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal sized thyroid gland n1=hypoaldostéronisme | n2=en:normal sized thyroid gland | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal testosterone level n1=hypoaldostéronisme | n2=en:normal testosterone level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal testosterone levels in adulthood n1=hypoaldostéronisme | n2=en:normal testosterone levels in adulthood | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:normal thyroid-stimulating hormone level n1=hypoaldostéronisme | n2=en:normal thyroid-stimulating hormone level | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:nr5a1 gene n1=hypoaldostéronisme | n2=en:nr5a1 gene | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:nutritional and metabolic cardiomyopathy n1=hypoaldostéronisme | n2=en:nutritional and metabolic cardiomyopathy | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:oestradiol decreased n1=hypoaldostéronisme | n2=en:oestradiol decreased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:oligomenorrhea n1=hypoaldostéronisme | n2=en:oligomenorrhea | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:other adrenal hypofunction n1=hypoaldostéronisme | n2=en:other adrenal hypofunction | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:other specified disorders of adrenal gland n1=hypoaldostéronisme | n2=en:other specified disorders of adrenal gland | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:ovarian failure, premature n1=hypoaldostéronisme | n2=en:ovarian failure, premature | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:ovarian hyperandrogenemia n1=hypoaldostéronisme | n2=en:ovarian hyperandrogenemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:oxalosis n1=hypoaldostéronisme | n2=en:oxalosis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pancreatic exocrine deficiency n1=hypoaldostéronisme | n2=en:pancreatic exocrine deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:panhypopituitarism n1=hypoaldostéronisme | n2=en:panhypopituitarism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:parasitology n1=hypoaldostéronisme | n2=en:parasitology | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:parathyroid gland adenoma n1=hypoaldostéronisme | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:parathyroid hormone decreased n1=hypoaldostéronisme | n2=en:parathyroid hormone decreased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:parathyroid hyperplasia n1=hypoaldostéronisme | n2=en:parathyroid hyperplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:parathyroid hyperplasia, benign n1=hypoaldostéronisme | n2=en:parathyroid hyperplasia, benign | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:parathyroid hypoplasia n1=hypoaldostéronisme | n2=en:parathyroid hypoplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:partial deficiency of cytoplasmic dht-binding n1=hypoaldostéronisme | n2=en:partial deficiency of cytoplasmic dht-binding | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:partial or complete serum gonadotropin deficiency n1=hypoaldostéronisme | n2=en:partial or complete serum gonadotropin deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pathological aspects n1=hypoaldostéronisme | n2=en:pathological aspects | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:patients have normal pituitary function n1=hypoaldostéronisme | n2=en:patients have normal pituitary function | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:patients with hypothyroidism have hypoplastic thyroid gland n1=hypoaldostéronisme | n2=en:patients with hypothyroidism have hypoplastic thyroid gland | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pharmacotherapeutic n1=hypoaldostéronisme | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:physiopathological n1=hypoaldostéronisme | n2=en:physiopathological | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pigmented micronodular adrenal dysplasia n1=hypoaldostéronisme | n2=en:pigmented micronodular adrenal dysplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pigmented micronodular adrenocortical disease n1=hypoaldostéronisme | n2=en:pigmented micronodular adrenocortical disease | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary agenesis n1=hypoaldostéronisme | n2=en:pituitary agenesis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary amphophil hyperplasia n1=hypoaldostéronisme | n2=en:pituitary amphophil hyperplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary anomalies n1=hypoaldostéronisme | n2=en:pituitary anomalies | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary defects n1=hypoaldostéronisme | n2=en:pituitary defects | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary dwarfism n1=hypoaldostéronisme | n2=en:pituitary dwarfism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary gland adenoma n1=hypoaldostéronisme | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary hormone deficiencies (in some patients) n1=hypoaldostéronisme | n2=en:pituitary hormone deficiencies (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pituitary hormone deficiency n1=hypoaldostéronisme | n2=en:pituitary hormone deficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:plasma aldosterone increased n1=hypoaldostéronisme | n2=en:plasma aldosterone increased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:polyglandular type i autoimmune syndrome n1=hypoaldostéronisme | n2=en:polyglandular type i autoimmune syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:poor secondary sexual development (1 family) n1=hypoaldostéronisme | n2=en:poor secondary sexual development (1 family) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:post-adrenalectomy adrenal insufficiency n1=hypoaldostéronisme | n2=en:post-adrenalectomy adrenal insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:postprocedural hypothyroidism n1=hypoaldostéronisme | n2=en:postprocedural hypothyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:precocious puberty n1=hypoaldostéronisme | n2=en:precocious puberty | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:precocious puberty (less common) n1=hypoaldostéronisme | n2=en:precocious puberty (less common) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:precocious puberty in males n1=hypoaldostéronisme | n2=en:precocious puberty in males | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:premature adrenarche n1=hypoaldostéronisme | n2=en:premature adrenarche | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:premature menopause n1=hypoaldostéronisme | n2=en:premature menopause | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:premature menopause (in a subset of patients) n1=hypoaldostéronisme | n2=en:premature menopause (in a subset of patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:premature ovarian failure (less common) n1=hypoaldostéronisme | n2=en:premature ovarian failure (less common) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:premature pubertal stimulated levels of lh n1=hypoaldostéronisme | n2=en:premature pubertal stimulated levels of lh | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:premature thelarche n1=hypoaldostéronisme | n2=en:premature thelarche | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:primary adrenal glucocorticoid excess n1=hypoaldostéronisme | n2=en:primary adrenal glucocorticoid excess | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:primary adrenal insufficiency n1=hypoaldostéronisme | n2=en:primary adrenal insufficiency | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:primary amenorrhea n1=hypoaldostéronisme | n2=en:primary amenorrhea | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:primary amenorrhea (in a subset of patients) n1=hypoaldostéronisme | n2=en:primary amenorrhea (in a subset of patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:primary hypothyroidism n1=hypoaldostéronisme | n2=en:primary hypothyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:primary hypothyroidism (reported in 2 patients) n1=hypoaldostéronisme | n2=en:primary hypothyroidism (reported in 2 patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:primary testicular failure n1=hypoaldostéronisme | n2=en:primary testicular failure | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:prolactin level normal n1=hypoaldostéronisme | n2=en:prolactin level normal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:prolactin-producing pituitary gland adenoma n1=hypoaldostéronisme | n2=en:prolactin-producing pituitary gland adenoma | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:prominent body odor n1=hypoaldostéronisme | n2=en:prominent body odor | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pseudohypoaldosteronism type 1 n1=hypoaldostéronisme | n2=en:pseudohypoaldosteronism type 1 | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:pseudohypoparathyroidism n1=hypoaldostéronisme | n2=en:pseudohypoparathyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:reactive hypoglycemia n1=hypoaldostéronisme | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:refeeding syndrome n1=hypoaldostéronisme | n2=en:refeeding syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:renal resistance to pth n1=hypoaldostéronisme | n2=en:renal resistance to pth | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:renal salt wasting n1=hypoaldostéronisme | n2=en:renal salt wasting | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:secondary amenorrhea n1=hypoaldostéronisme | n2=en:secondary amenorrhea | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:secondary amenorrhea (in a subset of patients) n1=hypoaldostéronisme | n2=en:secondary amenorrhea (in a subset of patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:secondary hyperparathyroidism n1=hypoaldostéronisme | n2=en:secondary hyperparathyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:sequential loss of anterior pituitary tropic hormones n1=hypoaldostéronisme | n2=en:sequential loss of anterior pituitary tropic hormones | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:serum estrogen decreased n1=hypoaldostéronisme | n2=en:serum estrogen decreased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:serum phosphorus normal or mildly elevated n1=hypoaldostéronisme | n2=en:serum phosphorus normal or mildly elevated | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:serum prolactin decreased n1=hypoaldostéronisme | n2=en:serum prolactin decreased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:sex-hormone binding globulin markedly elevated n1=hypoaldostéronisme | n2=en:sex-hormone binding globulin markedly elevated | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:small adrenal gland n1=hypoaldostéronisme | n2=en:small adrenal gland | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:small to absent parathyroid glands n1=hypoaldostéronisme | n2=en:small to absent parathyroid glands | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:stimulation of the renin/angiotensin/aldosterone axis n1=hypoaldostéronisme | n2=en:stimulation of the renin/angiotensin/aldosterone axis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:subclinical hypothyroidism n1=hypoaldostéronisme | n2=en:subclinical hypothyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:suprarenal artery aneurysm n1=hypoaldostéronisme | n2=en:suprarenal artery aneurysm | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:suprarenal artery embolus n1=hypoaldostéronisme | n2=en:suprarenal artery embolus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:surgical aspects n1=hypoaldostéronisme | n2=en:surgical aspects | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:taxonomic n1=hypoaldostéronisme | n2=en:taxonomic | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:tertiary hypothyroidism n1=hypoaldostéronisme | n2=en:tertiary hypothyroidism | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:testicular hypofunction due to defect in adrenocortical hormone synthesis n1=hypoaldostéronisme | n2=en:testicular hypofunction due to defect in adrenocortical hormone synthesis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:therapeutic aspects n1=hypoaldostéronisme | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid associated opthalmopathies n1=hypoaldostéronisme | n2=en:thyroid associated opthalmopathies | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid disease (less common) n1=hypoaldostéronisme | n2=en:thyroid disease (less common) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid dysplasia/aplasia n1=hypoaldostéronisme | n2=en:thyroid dysplasia/aplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid failure (in some patients) n1=hypoaldostéronisme | n2=en:thyroid failure (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid gland disorder n1=hypoaldostéronisme | n2=en:thyroid gland disorder | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid gland follicular adenoma n1=hypoaldostéronisme | n2=en:thyroid gland follicular adenoma | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid hyperplasia n1=hypoaldostéronisme | n2=en:thyroid hyperplasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid iodine accumulation defect n1=hypoaldostéronisme | n2=en:thyroid iodine accumulation defect | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid lymphangiectasia n1=hypoaldostéronisme | n2=en:thyroid lymphangiectasia | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid stimulating hormone normal n1=hypoaldostéronisme | n2=en:thyroid stimulating hormone normal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid storm n1=hypoaldostéronisme | n2=en:thyroid storm | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroid volume 22-66ml (adults) n1=hypoaldostéronisme | n2=en:thyroid volume 22-66ml (adults) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyrotoxic cardiomyopathy n1=hypoaldostéronisme | n2=en:thyrotoxic cardiomyopathy | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyrotoxic periodic paralysis n1=hypoaldostéronisme | n2=en:thyrotoxic periodic paralysis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroxin binding globulin decreased n1=hypoaldostéronisme | n2=en:thyroxin binding globulin decreased | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:thyroxin binding globulin normal n1=hypoaldostéronisme | n2=en:thyroxin binding globulin normal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:total and free thyroxine low-normal or subnormal n1=hypoaldostéronisme | n2=en:total and free thyroxine low-normal or subnormal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:total thyroxine to total triiodothyronine ratio markedly low n1=hypoaldostéronisme | n2=en:total thyroxine to total triiodothyronine ratio markedly low | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:toxic goiter n1=hypoaldostéronisme | n2=en:toxic goiter | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:toxic nodular goiter n1=hypoaldostéronisme | n2=en:toxic nodular goiter | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:transient hypothyroidism (in some patients) n1=hypoaldostéronisme | n2=en:transient hypothyroidism (in some patients) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:type 1 diabetes mellitus n1=hypoaldostéronisme | n2=en:type 1 diabetes mellitus | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:type 1 diabetes mellitus developed in some patients n1=hypoaldostéronisme | n2=en:type 1 diabetes mellitus developed in some patients | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:type 2 diabetes (in some) n1=hypoaldostéronisme | n2=en:type 2 diabetes (in some) | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:type i renal tubular acidosis n1=hypoaldostéronisme | n2=en:type i renal tubular acidosis | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:vasointestinal peptide tumor n1=hypoaldostéronisme | n2=en:vasointestinal peptide tumor | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:veterinary aspects n1=hypoaldostéronisme | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:viruses n1=hypoaldostéronisme | n2=en:viruses | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:waterhouse-friderichsen syndrome n1=hypoaldostéronisme | n2=en:waterhouse-friderichsen syndrome | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> en:waterhouse-friderichsen syndrome, meningococcal n1=hypoaldostéronisme | n2=en:waterhouse-friderichsen syndrome, meningococcal | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 145 / 0.404 -> hypo-aldostéronisme n1=hypoaldostéronisme | n2=hypo-aldostéronisme | rel=r_associated | relid=0 | w=145 hypoaldostéronisme -- r_associated #0: 135 / 0.376 -> en:hypoaldosteronism n1=hypoaldostéronisme | n2=en:hypoaldosteronism | rel=r_associated | relid=0 | w=135 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal anti-diuretic hormone n1=hypoaldostéronisme | n2=en:abnormal anti-diuretic hormone | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal corticosterone finding n1=hypoaldostéronisme | n2=en:abnormal corticosterone finding | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal cortisol n1=hypoaldostéronisme | n2=en:abnormal cortisol | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal estrogen n1=hypoaldostéronisme | n2=en:abnormal estrogen | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal norepinephrine n1=hypoaldostéronisme | n2=en:abnormal norepinephrine | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal pituitary follicle stimulating hormone n1=hypoaldostéronisme | n2=en:abnormal pituitary follicle stimulating hormone | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal thyroid hormone n1=hypoaldostéronisme | n2=en:abnormal thyroid hormone | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable n1=hypoaldostéronisme | n2=en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:absence of pubertal development n1=hypoaldostéronisme | n2=en:absence of pubertal development | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:absent or delayed puberty n1=hypoaldostéronisme | n2=en:absent or delayed puberty | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:accessory thyroid tissue n1=hypoaldostéronisme | n2=en:accessory thyroid tissue | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:acth-independent hypercortisolemia n1=hypoaldostéronisme | n2=en:acth-independent hypercortisolemia | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:adrenal crisis in neonatal period n1=hypoaldostéronisme | n2=en:adrenal crisis in neonatal period | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:adrenal gland neoplasm n1=hypoaldostéronisme | n2=en:adrenal gland neoplasm | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:adrenal hemorrhage n1=hypoaldostéronisme | n2=en:adrenal hemorrhage | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:adrenal insufficiency neonatal n1=hypoaldostéronisme | n2=en:adrenal insufficiency neonatal | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:aldosterone level increased above normal n1=hypoaldostéronisme | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:altered melatonin secretion n1=hypoaldostéronisme | n2=en:altered melatonin secretion | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:aspects of mortality statistics n1=hypoaldostéronisme | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:aspects of radionuclide imaging n1=hypoaldostéronisme | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:calcitonin decreased n1=hypoaldostéronisme | n2=en:calcitonin decreased | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:chemically induced n1=hypoaldostéronisme | n2=en:chemically induced | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:congenital absence of adrenal gland n1=hypoaldostéronisme | n2=en:congenital absence of adrenal gland | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:congenital absence of parathyroid gland n1=hypoaldostéronisme | n2=en:congenital absence of parathyroid gland | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:congenital absence of thymus n1=hypoaldostéronisme | n2=en:congenital absence of thymus | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:decreased fertility in females n1=hypoaldostéronisme | n2=en:decreased fertility in females | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:decreased secondary sexual characteristics (in a subset of patients) n1=hypoaldostéronisme | n2=en:decreased secondary sexual characteristics (in a subset of patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:decreased serum progesterone n1=hypoaldostéronisme | n2=en:decreased serum progesterone | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:decreased testosterone level n1=hypoaldostéronisme | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:delayed or incomplete puberty (1 family) n1=hypoaldostéronisme | n2=en:delayed or incomplete puberty (1 family) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:delayed puberty n1=hypoaldostéronisme | n2=en:delayed puberty | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:diabetes (in affected males) n1=hypoaldostéronisme | n2=en:diabetes (in affected males) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:diabetes mellitus (in some patients) n1=hypoaldostéronisme | n2=en:diabetes mellitus (in some patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:diabetes mellitus, insulin-dependent (1 patient) n1=hypoaldostéronisme | n2=en:diabetes mellitus, insulin-dependent (1 patient) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:disease of adrenal medulla n1=hypoaldostéronisme | n2=en:disease of adrenal medulla | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:early-onset puberty (menarche about 2 years early) n1=hypoaldostéronisme | n2=en:early-onset puberty (menarche about 2 years early) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:elevated aldosterone n1=hypoaldostéronisme | n2=en:elevated aldosterone | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:elevated androgen metabolite excretion level n1=hypoaldostéronisme | n2=en:elevated androgen metabolite excretion level | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect) n1=hypoaldostéronisme | n2=en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:endocrine glands with iron deposition n1=hypoaldostéronisme | n2=en:endocrine glands with iron deposition | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:enlarged thyroid gland (rare) n1=hypoaldostéronisme | n2=en:enlarged thyroid gland (rare) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:ethnologic n1=hypoaldostéronisme | n2=en:ethnologic | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:etiology aspects n1=hypoaldostéronisme | n2=en:etiology aspects | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:eunuchoid appearance of males n1=hypoaldostéronisme | n2=en:eunuchoid appearance of males | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:euthyroid multinodular goiter n1=hypoaldostéronisme | n2=en:euthyroid multinodular goiter | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:failure of secondary sexual development n1=hypoaldostéronisme | n2=en:failure of secondary sexual development | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:follicle stimulating hormone deficiency n1=hypoaldostéronisme | n2=en:follicle stimulating hormone deficiency | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:genetic aspects n1=hypoaldostéronisme | n2=en:genetic aspects | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:growth hormone deficiency (1 patient) n1=hypoaldostéronisme | n2=en:growth hormone deficiency (1 patient) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:growth hormone deficiency (hcs) n1=hypoaldostéronisme | n2=en:growth hormone deficiency (hcs) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:high luteinizing hormone levels n1=hypoaldostéronisme | n2=en:high luteinizing hormone levels | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hyperadrenergic postural hypotension n1=hypoaldostéronisme | n2=en:hyperadrenergic postural hypotension | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hyperglycemia n1=hypoaldostéronisme | n2=en:hyperglycemia | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hypergonadotropic hypogonadism (males) n1=hypoaldostéronisme | n2=en:hypergonadotropic hypogonadism (males) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hyperinsulinemia (in male patient) n1=hypoaldostéronisme | n2=en:hyperinsulinemia (in male patient) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hyperlipasaemia n1=hypoaldostéronisme | n2=en:hyperlipasaemia | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hypermetabolism n1=hypoaldostéronisme | n2=en:hypermetabolism | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hyperproinsulinemia (asymptomatic in some patients) n1=hypoaldostéronisme | n2=en:hyperproinsulinemia (asymptomatic in some patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hyperreninemic hypoaldosteronism, familial, 2 n1=hypoaldostéronisme | n2=en:hyperreninemic hypoaldosteronism, familial, 2 | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hypogonadotropic hypogonadism (in some patients) n1=hypoaldostéronisme | n2=en:hypogonadotropic hypogonadism (in some patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hypogonadotropic hypogonadism (rare) n1=hypoaldostéronisme | n2=en:hypogonadotropic hypogonadism (rare) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hypopituitarism (in some patients) n1=hypoaldostéronisme | n2=en:hypopituitarism (in some patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:hypothyroidism, autoantibody-positive (in some patients) n1=hypoaldostéronisme | n2=en:hypothyroidism, autoantibody-positive (in some patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:increased baseline gonadotropins n1=hypoaldostéronisme | n2=en:increased baseline gonadotropins | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:increased thyroxine level n1=hypoaldostéronisme | n2=en:increased thyroxine level | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:insulin resistance n1=hypoaldostéronisme | n2=en:insulin resistance | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:insulin-like growth factor slightly low n1=hypoaldostéronisme | n2=en:insulin-like growth factor slightly low | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:irregular menstruation n1=hypoaldostéronisme | n2=en:irregular menstruation | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:klinefelter syndrome n1=hypoaldostéronisme | n2=en:klinefelter syndrome | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low adh (in some patients) n1=hypoaldostéronisme | n2=en:low adh (in some patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low c-peptide levels n1=hypoaldostéronisme | n2=en:low c-peptide levels | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low estradiol levels n1=hypoaldostéronisme | n2=en:low estradiol levels | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low estradiol levels in females n1=hypoaldostéronisme | n2=en:low estradiol levels in females | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low insulin-like growth factor-1 (igf1) concentration n1=hypoaldostéronisme | n2=en:low insulin-like growth factor-1 (igf1) concentration | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low serum leptin levels (in most patients) n1=hypoaldostéronisme | n2=en:low serum leptin levels (in most patients) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low serum testosterone in males n1=hypoaldostéronisme | n2=en:low serum testosterone in males | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low testosterone in males n1=hypoaldostéronisme | n2=en:low testosterone in males | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:low urinary cortols-to-cortolone ratio n1=hypoaldostéronisme | n2=en:low urinary cortols-to-cortolone ratio | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:maturity-onset diabetes of the young (rare) n1=hypoaldostéronisme | n2=en:maturity-onset diabetes of the young (rare) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:normal anterior pituitary function n1=hypoaldostéronisme | n2=en:normal anterior pituitary function | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:normal growth hormone studies n1=hypoaldostéronisme | n2=en:normal growth hormone studies | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:normal luteinizing hormone (lh) n1=hypoaldostéronisme | n2=en:normal luteinizing hormone (lh) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:normal response to exogenously administered insulin n1=hypoaldostéronisme | n2=en:normal response to exogenously administered insulin | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:other adrenocortical insufficiency n1=hypoaldostéronisme | n2=en:other adrenocortical insufficiency | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:other adrenocortical overactivity n1=hypoaldostéronisme | n2=en:other adrenocortical overactivity | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:other and unspecified adrenocortical insufficiency n1=hypoaldostéronisme | n2=en:other and unspecified adrenocortical insufficiency | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:pancreatic insulinoma n1=hypoaldostéronisme | n2=en:pancreatic insulinoma | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:parathyroid hormone levels low to low-normal n1=hypoaldostéronisme | n2=en:parathyroid hormone levels low to low-normal | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:partial growth hormone deficiency n1=hypoaldostéronisme | n2=en:partial growth hormone deficiency | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:pediatric adverse events terminology n1=hypoaldostéronisme | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:pituitary hypothyroidism n1=hypoaldostéronisme | n2=en:pituitary hypothyroidism | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:plasma dihydrotestosterone (dht) is decreased n1=hypoaldostéronisme | n2=en:plasma dihydrotestosterone (dht) is decreased | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:premature pubarche (in 1 female patient) n1=hypoaldostéronisme | n2=en:premature pubarche (in 1 female patient) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:prolactin, increased n1=hypoaldostéronisme | n2=en:prolactin, increased | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:psychology qualifier n1=hypoaldostéronisme | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:secondary sexual characteristics lacking n1=hypoaldostéronisme | n2=en:secondary sexual characteristics lacking | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:serum aldosterone elevated n1=hypoaldostéronisme | n2=en:serum aldosterone elevated | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:serum testosterone decreased n1=hypoaldostéronisme | n2=en:serum testosterone decreased | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:solitary parathyroid adenomas (rarely multiple) n1=hypoaldostéronisme | n2=en:solitary parathyroid adenomas (rarely multiple) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:stein-leventhal syndrome n1=hypoaldostéronisme | n2=en:stein-leventhal syndrome | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:steroid withdrawal syndrome n1=hypoaldostéronisme | n2=en:steroid withdrawal syndrome | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:subset of patients with ovarioleukodystrophy have primary amenorrhea n1=hypoaldostéronisme | n2=en:subset of patients with ovarioleukodystrophy have primary amenorrhea | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:testosterone excess n1=hypoaldostéronisme | n2=en:testosterone excess | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:thyroid defect in oxidation and organification of iodide n1=hypoaldostéronisme | n2=en:thyroid defect in oxidation and organification of iodide | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:thyroid function normal n1=hypoaldostéronisme | n2=en:thyroid function normal | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:thyroiditis n1=hypoaldostéronisme | n2=en:thyroiditis | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:total and free triiodothyronine high-normal or elevated n1=hypoaldostéronisme | n2=en:total and free triiodothyronine high-normal or elevated | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:truncal obesity (rare) n1=hypoaldostéronisme | n2=en:truncal obesity (rare) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:tuberculous addison's disease n1=hypoaldostéronisme | n2=en:tuberculous addison's disease | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:type 2 diabetes mellitus (t2d) n1=hypoaldostéronisme | n2=en:type 2 diabetes mellitus (t2d) | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 130 / 0.362 -> en:urinary 17-oxosteroids normal n1=hypoaldostéronisme | n2=en:urinary 17-oxosteroids normal | rel=r_associated | relid=0 | w=130 hypoaldostéronisme -- r_associated #0: 85 / 0.237 -> hyperkaliémie chronique n1=hypoaldostéronisme | n2=hyperkaliémie chronique | rel=r_associated | relid=0 | w=85 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:abnormal pituitary luteinizing hormone n1=hypoaldostéronisme | n2=en:abnormal pituitary luteinizing hormone | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:abnormal steroid hormone n1=hypoaldostéronisme | n2=en:abnormal steroid hormone | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:abnormal virilization n1=hypoaldostéronisme | n2=en:abnormal virilization | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:adrenal cortex adenoma n1=hypoaldostéronisme | n2=en:adrenal cortex adenoma | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:adrenal crisis n1=hypoaldostéronisme | n2=en:adrenal crisis | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:adrenal gland disorders nec n1=hypoaldostéronisme | n2=en:adrenal gland disorders nec | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:adrenocortical insufficiency (uncommon) n1=hypoaldostéronisme | n2=en:adrenocortical insufficiency (uncommon) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:adrenoleukodystrophy n1=hypoaldostéronisme | n2=en:adrenoleukodystrophy | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:amenorrhea n1=hypoaldostéronisme | n2=en:amenorrhea | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:carotenemia n1=hypoaldostéronisme | n2=en:carotenemia | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:central hypothyroidism n1=hypoaldostéronisme | n2=en:central hypothyroidism | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:complex adrenal endocrine disorder n1=hypoaldostéronisme | n2=en:complex adrenal endocrine disorder | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:congenital adrenal hyperplasia n1=hypoaldostéronisme | n2=en:congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:congenital anomaly of adrenal gland n1=hypoaldostéronisme | n2=en:congenital anomaly of adrenal gland | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:congenital hyperthyroidism n1=hypoaldostéronisme | n2=en:congenital hyperthyroidism | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:crystal nephropathy n1=hypoaldostéronisme | n2=en:crystal nephropathy | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:delay in secondary sexual characteristics n1=hypoaldostéronisme | n2=en:delay in secondary sexual characteristics | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:dysfunction of hypothalamo-pituitary-gonadal axis n1=hypoaldostéronisme | n2=en:dysfunction of hypothalamo-pituitary-gonadal axis | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:ectopic or absent posterior pituitary n1=hypoaldostéronisme | n2=en:ectopic or absent posterior pituitary | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:elevated serum adiponectin n1=hypoaldostéronisme | n2=en:elevated serum adiponectin | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:elevated serum estrone (in male and female patients) n1=hypoaldostéronisme | n2=en:elevated serum estrone (in male and female patients) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:elevated thyroid stimulating hormone (tsh) n1=hypoaldostéronisme | n2=en:elevated thyroid stimulating hormone (tsh) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:endocrine dysgenesis n1=hypoaldostéronisme | n2=en:endocrine dysgenesis | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:familial adrenocortical hypoplasia n1=hypoaldostéronisme | n2=en:familial adrenocortical hypoplasia | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:fatigue n1=hypoaldostéronisme | n2=en:fatigue | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:free thyroxine to free triiodothyronine ratio markedly low n1=hypoaldostéronisme | n2=en:free thyroxine to free triiodothyronine ratio markedly low | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:glucocorticoid resistance n1=hypoaldostéronisme | n2=en:glucocorticoid resistance | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:growth hormone deficiency n1=hypoaldostéronisme | n2=en:growth hormone deficiency | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:growth hormone excess n1=hypoaldostéronisme | n2=en:growth hormone excess | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:high fsh secondary to androgen insensitivity n1=hypoaldostéronisme | n2=en:high fsh secondary to androgen insensitivity | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hyperaldosteronemia n1=hypoaldostéronisme | n2=en:hyperaldosteronemia | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hyperaldosteronemia (rare) n1=hypoaldostéronisme | n2=en:hyperaldosteronemia (rare) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hyperaldosteronism n1=hypoaldostéronisme | n2=en:hyperaldosteronism | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypergonadotropic hypogonadism n1=hypoaldostéronisme | n2=en:hypergonadotropic hypogonadism | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypergonadotropic hypogonadism (in a subset of patients) n1=hypoaldostéronisme | n2=en:hypergonadotropic hypogonadism (in a subset of patients) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hyperinsulinemia (in some patients) n1=hypoaldostéronisme | n2=en:hyperinsulinemia (in some patients) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hyperprolactinemia n1=hypoaldostéronisme | n2=en:hyperprolactinemia | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hyperreninemia (rare) n1=hypoaldostéronisme | n2=en:hyperreninemia (rare) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypoadrenalism (rare) n1=hypoaldostéronisme | n2=en:hypoadrenalism (rare) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypogonadism (less common) n1=hypoaldostéronisme | n2=en:hypogonadism (less common) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypogonadotropic hypergonadism n1=hypoaldostéronisme | n2=en:hypogonadotropic hypergonadism | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypoplastic thyroid gland n1=hypoaldostéronisme | n2=en:hypoplastic thyroid gland | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypothyroidism (if untreated) n1=hypoaldostéronisme | n2=en:hypothyroidism (if untreated) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypothyroidism in subset of patients n1=hypoaldostéronisme | n2=en:hypothyroidism in subset of patients | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:hypothyroidism, nongoitrous n1=hypoaldostéronisme | n2=en:hypothyroidism, nongoitrous | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:impaired glucose tolerance (in some patients) n1=hypoaldostéronisme | n2=en:impaired glucose tolerance (in some patients) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:infertility n1=hypoaldostéronisme | n2=en:infertility | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:insulin-resistant diabetes mellitus n1=hypoaldostéronisme | n2=en:insulin-resistant diabetes mellitus | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:low-to-normal serum growth hormone n1=hypoaldostéronisme | n2=en:low-to-normal serum growth hormone | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:medulloadrenal hyperfunction n1=hypoaldostéronisme | n2=en:medulloadrenal hyperfunction | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:myxedema coma n1=hypoaldostéronisme | n2=en:myxedema coma | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:normal follicle-stimulating hormone (fsh) n1=hypoaldostéronisme | n2=en:normal follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:nursing therapy n1=hypoaldostéronisme | n2=en:nursing therapy | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:oestradiol increased n1=hypoaldostéronisme | n2=en:oestradiol increased | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:parathyroid hormone concentration low or low-normal n1=hypoaldostéronisme | n2=en:parathyroid hormone concentration low or low-normal | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:plasma testosterone is normal or increased n1=hypoaldostéronisme | n2=en:plasma testosterone is normal or increased | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:precocious puberty with sertoli cell tumor n1=hypoaldostéronisme | n2=en:precocious puberty with sertoli cell tumor | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:premature ovarian failure in female carriers n1=hypoaldostéronisme | n2=en:premature ovarian failure in female carriers | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:primary hyperthyroidism n1=hypoaldostéronisme | n2=en:primary hyperthyroidism | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:primary hypogonadism (in 2 male patients) n1=hypoaldostéronisme | n2=en:primary hypogonadism (in 2 male patients) | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:rehabilitation aspects n1=hypoaldostéronisme | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:syndrome of inappropriate antidiuretic hormone secretion n1=hypoaldostéronisme | n2=en:syndrome of inappropriate antidiuretic hormone secretion | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:thin pituitary stalk n1=hypoaldostéronisme | n2=en:thin pituitary stalk | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:thyroid follicular hyperplasia n1=hypoaldostéronisme | n2=en:thyroid follicular hyperplasia | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:thyroid gland papillary carcinoma n1=hypoaldostéronisme | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:type 2 diabetes mellitus n1=hypoaldostéronisme | n2=en:type 2 diabetes mellitus | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:urinary 17-hydroxycorticoids normal n1=hypoaldostéronisme | n2=en:urinary 17-hydroxycorticoids normal | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 35 / 0.097 -> en:use of ultrasonography n1=hypoaldostéronisme | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=35 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> acidose rénale tubulaire de type 4 n1=hypoaldostéronisme | n2=acidose rénale tubulaire de type 4 | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:abnormal 3,3' diiodothyronine n1=hypoaldostéronisme | n2=en:abnormal 3,3' diiodothyronine | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:abnormal glucagon n1=hypoaldostéronisme | n2=en:abnormal glucagon | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:abnormal secretin n1=hypoaldostéronisme | n2=en:abnormal secretin | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:absence of immune complexes and lymphocytes in thyroid tissue n1=hypoaldostéronisme | n2=en:absence of immune complexes and lymphocytes in thyroid tissue | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:acromegaly n1=hypoaldostéronisme | n2=en:acromegaly | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:addison's disease with adrenoleucodystrophy n1=hypoaldostéronisme | n2=en:addison's disease with adrenoleucodystrophy | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:adrenal adenomas, bilateral n1=hypoaldostéronisme | n2=en:adrenal adenomas, bilateral | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:adrenal gland injury n1=hypoaldostéronisme | n2=en:adrenal gland injury | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:adrenal gland myelolipoma n1=hypoaldostéronisme | n2=en:adrenal gland myelolipoma | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:adrenal glands may be normal, atrophic, or slightly enlarged n1=hypoaldostéronisme | n2=en:adrenal glands may be normal, atrophic, or slightly enlarged | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:adrenal hyperfunction n1=hypoaldostéronisme | n2=en:adrenal hyperfunction | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:adrenal insufficiency due to adrenal metastasis n1=hypoaldostéronisme | n2=en:adrenal insufficiency due to adrenal metastasis | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:adrenocortical insufficiency neonatal n1=hypoaldostéronisme | n2=en:adrenocortical insufficiency neonatal | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:allgrove syndrome n1=hypoaldostéronisme | n2=en:allgrove syndrome | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:congenital adrenal gland hypoplasia n1=hypoaldostéronisme | n2=en:congenital adrenal gland hypoplasia | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:corticosteroid deficiency n1=hypoaldostéronisme | n2=en:corticosteroid deficiency | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:cushing disease due to increased acth secretion (less common) n1=hypoaldostéronisme | n2=en:cushing disease due to increased acth secretion (less common) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:cushing syndrome n1=hypoaldostéronisme | n2=en:cushing syndrome | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:decreased fertility n1=hypoaldostéronisme | n2=en:decreased fertility | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:decreased growth hormone secretion (1 patient) n1=hypoaldostéronisme | n2=en:decreased growth hormone secretion (1 patient) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:diabetes mellitus, type 1 (rare) n1=hypoaldostéronisme | n2=en:diabetes mellitus, type 1 (rare) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:diabetes mellitus, type 2 (rare) n1=hypoaldostéronisme | n2=en:diabetes mellitus, type 2 (rare) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:early-onset puberty (in 2 of 3 patients) n1=hypoaldostéronisme | n2=en:early-onset puberty (in 2 of 3 patients) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:ectopic thyroid gland (finding) n1=hypoaldostéronisme | n2=en:ectopic thyroid gland (finding) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:elevated igf1 levels n1=hypoaldostéronisme | n2=en:elevated igf1 levels | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:elevated insulin n1=hypoaldostéronisme | n2=en:elevated insulin | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:elevated serum estradiol (in male and female patients) n1=hypoaldostéronisme | n2=en:elevated serum estradiol (in male and female patients) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:endocrine abnormalities, variable, (less common) n1=hypoaldostéronisme | n2=en:endocrine abnormalities, variable, (less common) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:enzyme induction n1=hypoaldostéronisme | n2=en:enzyme induction | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:enzyme inhibition disorder n1=hypoaldostéronisme | n2=en:enzyme inhibition disorder | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:episodic asymptomatic severe hypoglycemia in childhood n1=hypoaldostéronisme | n2=en:episodic asymptomatic severe hypoglycemia in childhood | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:exposure as collected domain n1=hypoaldostéronisme | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:few and small islets of langerhans n1=hypoaldostéronisme | n2=en:few and small islets of langerhans | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:functional anorchia n1=hypoaldostéronisme | n2=en:functional anorchia | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:glucocorticoid deficiency n1=hypoaldostéronisme | n2=en:glucocorticoid deficiency | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:glucose intolerance n1=hypoaldostéronisme | n2=en:glucose intolerance | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:growth hormone deficiency (2 patients) n1=hypoaldostéronisme | n2=en:growth hormone deficiency (2 patients) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:growth hormone deficiency (in 1/4 patients) n1=hypoaldostéronisme | n2=en:growth hormone deficiency (in 1/4 patients) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:growth hormone deficiency in some individuals n1=hypoaldostéronisme | n2=en:growth hormone deficiency in some individuals | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:high aldosterone/renin ratio n1=hypoaldostéronisme | n2=en:high aldosterone/renin ratio | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:high level of cortisone metabolites n1=hypoaldostéronisme | n2=en:high level of cortisone metabolites | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:high plasma cortisol n1=hypoaldostéronisme | n2=en:high plasma cortisol | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hyperbilirubinemia n1=hypoaldostéronisme | n2=en:hyperbilirubinemia | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypercalcemia n1=hypoaldostéronisme | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hyperglycemia (in some patients) n1=hypoaldostéronisme | n2=en:hyperglycemia (in some patients) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypergonadotropic hypogonadism (reported in 1 female) n1=hypoaldostéronisme | n2=en:hypergonadotropic hypogonadism (reported in 1 female) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hyperoxalaemia n1=hypoaldostéronisme | n2=en:hyperoxalaemia | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hyperparathyroidism n1=hypoaldostéronisme | n2=en:hyperparathyroidism | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypoaldosteronism, transient, isolated n1=hypoaldostéronisme | n2=en:hypoaldosteronism, transient, isolated | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypoglycemia, fasting n1=hypoaldostéronisme | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypomagnesemia n1=hypoaldostéronisme | n2=en:hypomagnesemia | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypophyseal agenesis n1=hypoaldostéronisme | n2=en:hypophyseal agenesis | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypopituitarism n1=hypoaldostéronisme | n2=en:hypopituitarism | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:hypothalamic-adrenal dysfunction n1=hypoaldostéronisme | n2=en:hypothalamic-adrenal dysfunction | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:immunology aspects n1=hypoaldostéronisme | n2=en:immunology aspects | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:in urine n1=hypoaldostéronisme | n2=en:in urine | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:increased circulating gonadotropin level n1=hypoaldostéronisme | n2=en:increased circulating gonadotropin level | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:insulin resistance (in some patients) n1=hypoaldostéronisme | n2=en:insulin resistance (in some patients) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:insulin-resistant diabetes mellitus (onset around puberty) n1=hypoaldostéronisme | n2=en:insulin-resistant diabetes mellitus (onset around puberty) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:insulin-resistant diabetes mellitus in adulthood n1=hypoaldostéronisme | n2=en:insulin-resistant diabetes mellitus in adulthood | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:isolated glucocorticoid deficiency n1=hypoaldostéronisme | n2=en:isolated glucocorticoid deficiency | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:late menarche n1=hypoaldostéronisme | n2=en:late menarche | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:low estradiol in females n1=hypoaldostéronisme | n2=en:low estradiol in females | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:low or absent growth hormone n1=hypoaldostéronisme | n2=en:low or absent growth hormone | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:low serum gonadotropins n1=hypoaldostéronisme | n2=en:low serum gonadotropins | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:low to normal level of cortisol metabolites n1=hypoaldostéronisme | n2=en:low to normal level of cortisol metabolites | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:low to undetectable gonadotropin levels n1=hypoaldostéronisme | n2=en:low to undetectable gonadotropin levels | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:macroamylasemia n1=hypoaldostéronisme | n2=en:macroamylasemia | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:marked increase in pregnanetriolone after hcg or acth stimulation n1=hypoaldostéronisme | n2=en:marked increase in pregnanetriolone after hcg or acth stimulation | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:microbiological n1=hypoaldostéronisme | n2=en:microbiological | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates n1=hypoaldostéronisme | n2=en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:multiple endocrine neoplasia type 2b n1=hypoaldostéronisme | n2=en:multiple endocrine neoplasia type 2b | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:nutritional management n1=hypoaldostéronisme | n2=en:nutritional management | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:pancreatitis n1=hypoaldostéronisme | n2=en:pancreatitis | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:pediatric terminology n1=hypoaldostéronisme | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:pituitary hypoplasia (in some patients) n1=hypoaldostéronisme | n2=en:pituitary hypoplasia (in some patients) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:postprocedural adrenocortical(-medullary) hypofunction n1=hypoaldostéronisme | n2=en:postprocedural adrenocortical(-medullary) hypofunction | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:pregnanetriolone (ptl) present in urine n1=hypoaldostéronisme | n2=en:pregnanetriolone (ptl) present in urine | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:premature pubertal basal levels of luteinizing hormone (lh) n1=hypoaldostéronisme | n2=en:premature pubertal basal levels of luteinizing hormone (lh) | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:progesterone undetectable n1=hypoaldostéronisme | n2=en:progesterone undetectable | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:pseudophaeochromocytoma n1=hypoaldostéronisme | n2=en:pseudophaeochromocytoma | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:radiotherapeutic n1=hypoaldostéronisme | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:roentgenographic n1=hypoaldostéronisme | n2=en:roentgenographic | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:secondary adrenal insufficiency n1=hypoaldostéronisme | n2=en:secondary adrenal insufficiency | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:thyroid hormone tests abnormal n1=hypoaldostéronisme | n2=en:thyroid hormone tests abnormal | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 30 / 0.084 -> en:undervirilization n1=hypoaldostéronisme | n2=en:undervirilization | rel=r_associated | relid=0 | w=30 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> en:acute fulminating meningococcemia n1=hypoaldostéronisme | n2=en:acute fulminating meningococcemia | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> en:chronic hyperkaliemia n1=hypoaldostéronisme | n2=en:chronic hyperkaliemia | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> en:pseudohypoaldosteronism n1=hypoaldostéronisme | n2=en:pseudohypoaldosteronism | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> en:Waterhouse-Friderichsen syndrome n1=hypoaldostéronisme | n2=en:Waterhouse-Friderichsen syndrome | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> en:Waterhouse-Friderichsen's syndrome n1=hypoaldostéronisme | n2=en:Waterhouse-Friderichsen's syndrome | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> en:Waterhouse-Fridrichsen's syndrome n1=hypoaldostéronisme | n2=en:Waterhouse-Fridrichsen's syndrome | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> hypoaldostéronisme de type II n1=hypoaldostéronisme | n2=hypoaldostéronisme de type II | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> insuffisance corticale surrénalienne n1=hypoaldostéronisme | n2=insuffisance corticale surrénalienne | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> insuffisance cortico-surrénale n1=hypoaldostéronisme | n2=insuffisance cortico-surrénale | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> pseudo hypoaldostéronisme de type I n1=hypoaldostéronisme | n2=pseudo hypoaldostéronisme de type I | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> pseudo hypoaldostéronisme de type II n1=hypoaldostéronisme | n2=pseudo hypoaldostéronisme de type II | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> pseudo-hyperaldostéronisme n1=hypoaldostéronisme | n2=pseudo-hyperaldostéronisme | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> pseudo-hypoaldostéronisme n1=hypoaldostéronisme | n2=pseudo-hypoaldostéronisme | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> pseudohypoaldostéronisme n1=hypoaldostéronisme | n2=pseudohypoaldostéronisme | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> syndrome de waterhouse-friderichsen n1=hypoaldostéronisme | n2=syndrome de waterhouse-friderichsen | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 20 / 0.056 -> Waterhouse-Friderichsen (syndrome de) n1=hypoaldostéronisme | n2=Waterhouse-Friderichsen (syndrome de) | rel=r_associated | relid=0 | w=20 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:delayed puberty (in most patients) n1=hypoaldostéronisme | n2=en:delayed puberty (in most patients) | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:ectopic thyroid gland n1=hypoaldostéronisme | n2=en:ectopic thyroid gland | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:elevated baseline 17-hydroxypregnenolone levels n1=hypoaldostéronisme | n2=en:elevated baseline 17-hydroxypregnenolone levels | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:elevated fasting plasma glucose n1=hypoaldostéronisme | n2=en:elevated fasting plasma glucose | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:elevated gonadotropin levels n1=hypoaldostéronisme | n2=en:elevated gonadotropin levels | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:low serum igf2 levels n1=hypoaldostéronisme | n2=en:low serum igf2 levels | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:low to normal estradiol levels n1=hypoaldostéronisme | n2=en:low to normal estradiol levels | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:normal basal plasma cortisol n1=hypoaldostéronisme | n2=en:normal basal plasma cortisol | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:normal serum igfbp3 levels n1=hypoaldostéronisme | n2=en:normal serum igfbp3 levels | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 10 / 0.028 -> en:thyroid oncocytic metaplasia n1=hypoaldostéronisme | n2=en:thyroid oncocytic metaplasia | rel=r_associated | relid=0 | w=10 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> acromégalie n1=hypoaldostéronisme | n2=acromégalie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens n1=hypoaldostéronisme | n2=acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> acromegaly n1=hypoaldostéronisme | n2=acromegaly | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> adréno-leucodystrophie n1=hypoaldostéronisme | n2=adréno-leucodystrophie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> adrénoleucodystrophie n1=hypoaldostéronisme | n2=adrénoleucodystrophie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> adrénoleucodystrophie liée à l'X n1=hypoaldostéronisme | n2=adrénoleucodystrophie liée à l'X | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> amn n1=hypoaldostéronisme | n2=amn | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> bilirubinémie n1=hypoaldostéronisme | n2=bilirubinémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> coma myxoedémateux n1=hypoaldostéronisme | n2=coma myxoedémateux | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> déficit en hormone de croissance n1=hypoaldostéronisme | n2=déficit en hormone de croissance | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> diabète (accidents vasculaires cérébraux du) n1=hypoaldostéronisme | n2=diabète (accidents vasculaires cérébraux du) | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> diabète sucré n1=hypoaldostéronisme | n2=diabète sucré | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> diabète sucré de type 2 avec surdité n1=hypoaldostéronisme | n2=diabète sucré de type 2 avec surdité | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale n1=hypoaldostéronisme | n2=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:acyesis n1=hypoaldostéronisme | n2=en:acyesis | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:addison disease n1=hypoaldostéronisme | n2=en:addison disease | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:Addison disease n1=hypoaldostéronisme | n2=en:Addison disease | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:Addison's disease n1=hypoaldostéronisme | n2=en:Addison's disease | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:adrenal agenesis/dysgenesis n1=hypoaldostéronisme | n2=en:adrenal agenesis/dysgenesis | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:hyperandrogenism n1=hypoaldostéronisme | n2=en:hyperandrogenism | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:hypercalcaemia n1=hypoaldostéronisme | n2=en:hypercalcaemia | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:hypogonadotrophic hypogonadism n1=hypoaldostéronisme | n2=en:hypogonadotrophic hypogonadism | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:hypothalamic hamartoblastoma n1=hypoaldostéronisme | n2=en:hypothalamic hamartoblastoma | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:hypothyreosis n1=hypoaldostéronisme | n2=en:hypothyreosis | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:hypothyroidy n1=hypoaldostéronisme | n2=en:hypothyroidy | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:infertilitas feminis n1=hypoaldostéronisme | n2=en:infertilitas feminis | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:Klinefelter syndrome n1=hypoaldostéronisme | n2=en:Klinefelter syndrome | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:laboratory test result n1=hypoaldostéronisme | n2=en:laboratory test result | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:nasal alar hypoplasia n1=hypoaldostéronisme | n2=en:nasal alar hypoplasia | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:overactive thyroid n1=hypoaldostéronisme | n2=en:overactive thyroid | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:photomyoclonus n1=hypoaldostéronisme | n2=en:photomyoclonus | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:renal tubulopathy n1=hypoaldostéronisme | n2=en:renal tubulopathy | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:sugar diabetes n1=hypoaldostéronisme | n2=en:sugar diabetes | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> en:urophtisis n1=hypoaldostéronisme | n2=en:urophtisis | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne n1=hypoaldostéronisme | n2=encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> enzymologie n1=hypoaldostéronisme | n2=enzymologie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> enzymology n1=hypoaldostéronisme | n2=enzymology | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> épidémiologique n1=hypoaldostéronisme | n2=épidémiologique | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> glucagonome (syndrome du) n1=hypoaldostéronisme | n2=glucagonome (syndrome du) | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale n1=hypoaldostéronisme | n2=hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperaldostéronisme n1=hypoaldostéronisme | n2=hyperaldostéronisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperamylasémie n1=hypoaldostéronisme | n2=hyperamylasémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperandrogénie n1=hypoaldostéronisme | n2=hyperandrogénie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperandrogénisme n1=hypoaldostéronisme | n2=hyperandrogénisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperbilirubinémie n1=hypoaldostéronisme | n2=hyperbilirubinémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypercalcémie n1=hypoaldostéronisme | n2=hypercalcémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperoxalémie n1=hypoaldostéronisme | n2=hyperoxalémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperplasie congénitale des surrénales n1=hypoaldostéronisme | n2=hyperplasie congénitale des surrénales | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperthyroïdie n1=hypoaldostéronisme | n2=hyperthyroïdie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hyperthyroïdisme n1=hypoaldostéronisme | n2=hyperthyroïdisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypocalcémie n1=hypoaldostéronisme | n2=hypocalcémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypoglycémie du nouveau-né n1=hypoaldostéronisme | n2=hypoglycémie du nouveau-né | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypogonadisme hypogonadotrophique n1=hypoaldostéronisme | n2=hypogonadisme hypogonadotrophique | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypohypophysie n1=hypoaldostéronisme | n2=hypohypophysie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypopituitarisme n1=hypoaldostéronisme | n2=hypopituitarisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale n1=hypoaldostéronisme | n2=hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypostimulinie n1=hypoaldostéronisme | n2=hypostimulinie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypothyroïdie n1=hypoaldostéronisme | n2=hypothyroïdie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> hypothyroïdisme n1=hypoaldostéronisme | n2=hypothyroïdisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> infertilité de la femme n1=hypoaldostéronisme | n2=infertilité de la femme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> infertilité féminine n1=hypoaldostéronisme | n2=infertilité féminine | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> insuffisance surrénale n1=hypoaldostéronisme | n2=insuffisance surrénale | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> insuffisance surrénalienne chronique primaire n1=hypoaldostéronisme | n2=insuffisance surrénalienne chronique primaire | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> macro-amylasémie n1=hypoaldostéronisme | n2=macro-amylasémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> macroamylasémie n1=hypoaldostéronisme | n2=macroamylasémie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> maladie d'Addison n1=hypoaldostéronisme | n2=maladie d'Addison | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> maladie d'addison n1=hypoaldostéronisme | n2=maladie d'addison | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> maladie métabolique n1=hypoaldostéronisme | n2=maladie métabolique | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> Médecine n1=hypoaldostéronisme | n2=Médecine | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> microbiologique n1=hypoaldostéronisme | n2=microbiologique | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> myélolipome n1=hypoaldostéronisme | n2=myélolipome | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> myélolipomes n1=hypoaldostéronisme | n2=myélolipomes | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> panhypopituitarisme n1=hypoaldostéronisme | n2=panhypopituitarisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> parasitologie n1=hypoaldostéronisme | n2=parasitologie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> pseudo-hypoparathyroïdie n1=hypoaldostéronisme | n2=pseudo-hypoparathyroïdie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> pseudo-hypoparathyroïdisme n1=hypoaldostéronisme | n2=pseudo-hypoparathyroïdisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> pseudohypoparathyroïdie n1=hypoaldostéronisme | n2=pseudohypoparathyroïdie | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> pseudohypoparathyroïdisme n1=hypoaldostéronisme | n2=pseudohypoparathyroïdisme | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> puberté précoce n1=hypoaldostéronisme | n2=puberté précoce | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> Puberté précoce n1=hypoaldostéronisme | n2=Puberté précoce | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> puberté rétardée n1=hypoaldostéronisme | n2=puberté rétardée | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> puberté retardée n1=hypoaldostéronisme | n2=puberté retardée | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> puberté tardive n1=hypoaldostéronisme | n2=puberté tardive | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> retard pubertaire n1=hypoaldostéronisme | n2=retard pubertaire | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> stérilité féminine n1=hypoaldostéronisme | n2=stérilité féminine | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> syndrome métabolique n1=hypoaldostéronisme | n2=syndrome métabolique | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> thyroïdite n1=hypoaldostéronisme | n2=thyroïdite | rel=r_associated | relid=0 | w=5 hypoaldostéronisme -- r_associated #0: 5 / 0.014 -> tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial n1=hypoaldostéronisme | n2=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | rel=r_associated | relid=0 | w=5

≈ 822 relations entrantes en:hypoaldosteronism --- r_associated #0: 194 --> hypoaldostéronisme n1=en:hypoaldosteronism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=194 hypo-aldostéronisme --- r_associated #0: 193 --> hypoaldostéronisme n1=hypo-aldostéronisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=193 en:hypoaldosteronemia --- r_associated #0: 190 --> hypoaldostéronisme n1=en:hypoaldosteronemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=190 médecine --- r_associated #0: 156 --> hypoaldostéronisme n1=médecine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=156 insuffisance corticosurrénale --- r_associated #0: 82 --> hypoaldostéronisme n1=insuffisance corticosurrénale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=82 insuffisance cortico-surrénale --- r_associated #0: 80 --> hypoaldostéronisme n1=insuffisance cortico-surrénale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=80 pseudo-hypoaldostéronisme --- r_associated #0: 74 --> hypoaldostéronisme n1=pseudo-hypoaldostéronisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=74 pseudohypoaldostéronisme --- r_associated #0: 73 --> hypoaldostéronisme n1=pseudohypoaldostéronisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=73 en:pseudohypoaldosteronism --- r_associated #0: 71 --> hypoaldostéronisme n1=en:pseudohypoaldosteronism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=71 pseudo hypoaldostéronisme de type I --- r_associated #0: 59 --> hypoaldostéronisme n1=pseudo hypoaldostéronisme de type I | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=59 pseudo hypoaldostéronisme de type II --- r_associated #0: 54 --> hypoaldostéronisme n1=pseudo hypoaldostéronisme de type II | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=54 syndrome de Waterhouse-Friderichsen --- r_associated #0: 52 --> hypoaldostéronisme n1=syndrome de Waterhouse-Friderichsen | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=52 hypoaldostéronisme de type II --- r_associated #0: 51 --> hypoaldostéronisme n1=hypoaldostéronisme de type II | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=51 en:Waterhouse-Friderichsen's syndrome --- r_associated #0: 50 --> hypoaldostéronisme n1=en:Waterhouse-Friderichsen's syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=50 syndrome de waterhouse-friderichsen --- r_associated #0: 50 --> hypoaldostéronisme n1=syndrome de waterhouse-friderichsen | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=50 en:Waterhouse-Fridrichsen's syndrome --- r_associated #0: 49 --> hypoaldostéronisme n1=en:Waterhouse-Fridrichsen's syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=49 Waterhouse-Friderichsen (syndrome de) --- r_associated #0: 40 --> hypoaldostéronisme n1=Waterhouse-Friderichsen (syndrome de) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=40 hyperkaliémie chronique --- r_associated #0: 40 --> hypoaldostéronisme n1=hyperkaliémie chronique | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=40 en:acute fulminating meningococcemia --- r_associated #0: 39 --> hypoaldostéronisme n1=en:acute fulminating meningococcemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=39 en:chronic hyperkaliemia --- r_associated #0: 38 --> hypoaldostéronisme n1=en:chronic hyperkaliemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=38 en:Waterhouse-Friderichsen syndrome --- r_associated #0: 37 --> hypoaldostéronisme n1=en:Waterhouse-Friderichsen syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=37 hypoaldostéronismes --- r_associated #0: 35 --> hypoaldostéronisme n1=hypoaldostéronismes | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=35 acidose rénale tubulaire de type 4 --- r_associated #0: 34 --> hypoaldostéronisme n1=acidose rénale tubulaire de type 4 | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=34 en:hypoaldosteronism, hyporeninemic --- r_associated #0: 31 --> hypoaldostéronisme n1=en:hypoaldosteronism, hyporeninemic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=31 hypoaldostéronisme hyporéninémique --- r_associated #0: 31 --> hypoaldostéronisme n1=hypoaldostéronisme hyporéninémique | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=31 infarctus de la surrénale --- r_associated #0: 31 --> hypoaldostéronisme n1=infarctus de la surrénale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=31 insuffisance corticale surrénalienne --- r_associated #0: 31 --> hypoaldostéronisme n1=insuffisance corticale surrénalienne | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=31 pseudo-hyperaldostéronisme --- r_associated #0: 29 --> hypoaldostéronisme n1=pseudo-hyperaldostéronisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=29 hémorragie de la surrénale --- r_associated #0: 28 --> hypoaldostéronisme n1=hémorragie de la surrénale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=28 hyperbilirubinémie --- r_associated #0: 25 --> hypoaldostéronisme n1=hyperbilirubinémie | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=25 hyperbilirubinémie du nouveau-né --- r_associated #0: 25 --> hypoaldostéronisme n1=hyperbilirubinémie du nouveau-né | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=25 hyperbilirubinémie néonatale --- r_associated #0: 25 --> hypoaldostéronisme n1=hyperbilirubinémie néonatale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=25 en:waterhouse-friderichsen syndrome --- r_associated #0: 23 --> hypoaldostéronisme n1=en:waterhouse-friderichsen syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=23 en:pseudo hypoaldosteronism --- r_associated #0: 21 --> hypoaldostéronisme n1=en:pseudo hypoaldosteronism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=21 processus pathologique --- r_associated #0: 21 --> hypoaldostéronisme n1=processus pathologique | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=21 bilirubinémie --- r_associated #0: 20 --> hypoaldostéronisme n1=bilirubinémie | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:'cytomegalic' cells (large, pale) in adrenal glands --- r_associated #0: 20 --> hypoaldostéronisme n1=en:'cytomegalic' cells (large, pale) in adrenal glands | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal 11-deoxy, 17-hydroxycorticosterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal 11-deoxy, 17-hydroxycorticosterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal 11-deoxycorticosterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal 11-deoxycorticosterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal 17-ketogenic steroids --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal 17-ketogenic steroids | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal 3,3' diiodothyronine --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal 3,3' diiodothyronine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal adrenal cortical hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal adrenal cortical hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal adrenocorticotropic hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal adrenocorticotropic hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal androgen --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal androgen | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal anti-diuretic hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal anti-diuretic hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal corticosterone finding --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal corticosterone finding | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal corticotropin releasing factor --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal corticotropin releasing factor | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal cortisol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal cortisol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal cortisone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal cortisone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal epinephrine --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal epinephrine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal estradiol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal estradiol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal estriol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal estriol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal estrogen --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal estrogen | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal glucagon --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal glucagon | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal glucose tolerance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal glucose tolerance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal glucose tolerance test --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal glucose tolerance test | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal growth hormone (139250) response to stimulus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal growth hormone (139250) response to stimulus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal human chorionic gonadotropin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal human chorionic gonadotropin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal human growth hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal human growth hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal melanocyte stimulating hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal melanocyte stimulating hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal norepinephrine --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal norepinephrine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal oxytocin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal oxytocin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal pituitary follicle stimulating hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal pituitary follicle stimulating hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal pituitary gonadotropin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal pituitary gonadotropin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal pituitary luteinizing hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal pituitary luteinizing hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal polypeptide hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal polypeptide hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal pregnanediol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal pregnanediol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal progesterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal progesterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal prolactin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal prolactin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal protein hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal protein hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal secretin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal secretin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal serotonin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal serotonin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal steroid hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal steroid hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal testosterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal testosterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal thyroid hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal thyroid hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal thyroid-stimulating hormone (tsh) response to thyrotropin-releasing hormone (trh) stimulation, variable | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal thyroxine --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal thyroxine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal triiodothyronine --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal triiodothyronine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal vanillylmandelic acid --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal vanillylmandelic acid | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormal virilization --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormal virilization | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:abnormality of cortisol-binding globulin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:abnormality of cortisol-binding globulin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:absence of immune complexes and lymphocytes in thyroid tissue --- r_associated #0: 20 --> hypoaldostéronisme n1=en:absence of immune complexes and lymphocytes in thyroid tissue | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:absence of pubertal development --- r_associated #0: 20 --> hypoaldostéronisme n1=en:absence of pubertal development | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:absent dehydroepiandrosterone-sulphate, even after acth stimulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:absent dehydroepiandrosterone-sulphate, even after acth stimulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:absent or delayed puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:absent or delayed puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:absent or low response to gonadotropin-releasing hormone stimulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:absent or low response to gonadotropin-releasing hormone stimulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:absent or minimal increase in pregnanetriol after hcg stimulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:absent or minimal increase in pregnanetriol after hcg stimulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:accessory thyroid tissue --- r_associated #0: 20 --> hypoaldostéronisme n1=en:accessory thyroid tissue | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:acquired porphyria --- r_associated #0: 20 --> hypoaldostéronisme n1=en:acquired porphyria | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:acral overgrowth --- r_associated #0: 20 --> hypoaldostéronisme n1=en:acral overgrowth | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:acromegaloid features --- r_associated #0: 20 --> hypoaldostéronisme n1=en:acromegaloid features | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:acromegaly --- r_associated #0: 20 --> hypoaldostéronisme n1=en:acromegaly | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:acth-independent hypercortisolemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:acth-independent hypercortisolemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:addison's disease --- r_associated #0: 20 --> hypoaldostéronisme n1=en:addison's disease | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:addison's disease with adrenoleucodystrophy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:addison's disease with adrenoleucodystrophy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal adenomas, bilateral --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal adenomas, bilateral | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal androgen deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal androgen deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal atrophy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal atrophy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal calcification --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal calcification | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal cortex adenoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal cortex adenoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal cortex diseases --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal cortex diseases | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal cortical hypofunction --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal cortical hypofunction | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal crisis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal crisis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal crisis in neonatal period --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal crisis in neonatal period | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal cyst --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal cyst | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal failure (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal failure (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland cytomegaly --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland cytomegaly | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland disorder --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland disorder | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland disorders nec --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland disorders nec | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland dysgenesis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland dysgenesis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland injury --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland injury | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland myelolipoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland myelolipoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland neoplasm --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland neoplasm | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal gland tuberculosis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal gland tuberculosis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal glands may be normal, atrophic, or slightly enlarged --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal glands may be normal, atrophic, or slightly enlarged | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal hemangiomas --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal hemangiomas | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal hemorrhage --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal hemorrhage | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal hyperfunction --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal hyperfunction | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal hyperplasia, bilateral --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal hyperplasia, bilateral | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal hypoplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal hypoplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal insufficiency due to adrenal metastasis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal insufficiency due to adrenal metastasis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal insufficiency neonatal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal insufficiency neonatal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal insufficiency, congenital (300200) in 'complex' form --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal insufficiency, congenital (300200) in 'complex' form | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal medullary insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal medullary insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenal necrosis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenal necrosis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocortical cytomegaly --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocortical cytomegaly | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocortical hypofunction, chronic primary congenital --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocortical hypofunction, chronic primary congenital | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocortical insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocortical insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocortical insufficiency (uncommon) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocortical insufficiency (uncommon) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocortical insufficiency neonatal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocortical insufficiency neonatal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocorticotropic hormone (acth)-resistant adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocorticotropic hormone deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocorticotropic hormone deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenocorticotropin deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenocorticotropin deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenogenital syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenogenital syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:adrenoleukodystrophy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:adrenoleukodystrophy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:age at natural menopause qtl --- r_associated #0: 20 --> hypoaldostéronisme n1=en:age at natural menopause qtl | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:alcohol-induced pseudo-cushing's syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:alcohol-induced pseudo-cushing's syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:aldosterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:aldosterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:aldosterone disorder --- r_associated #0: 20 --> hypoaldostéronisme n1=en:aldosterone disorder | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:aldosterone level increased above normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:aldosterone level increased above normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:aldosterone synthase deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:aldosterone synthase deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:allgrove syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:allgrove syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:altered melatonin secretion --- r_associated #0: 20 --> hypoaldostéronisme n1=en:altered melatonin secretion | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:amenorrhea --- r_associated #0: 20 --> hypoaldostéronisme n1=en:amenorrhea | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:androgen excess --- r_associated #0: 20 --> hypoaldostéronisme n1=en:androgen excess | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:androgen levels normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:androgen levels normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:anterior pituitary enlargement --- r_associated #0: 20 --> hypoaldostéronisme n1=en:anterior pituitary enlargement | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:anterior pituitary hypoplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:anterior pituitary hypoplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:aspects of mortality statistics --- r_associated #0: 20 --> hypoaldostéronisme n1=en:aspects of mortality statistics | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:aspects of radionuclide imaging --- r_associated #0: 20 --> hypoaldostéronisme n1=en:aspects of radionuclide imaging | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:autoimmune adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:autoimmune adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:autoimmune primary adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:autoimmune primary adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:autoimmune thyroiditis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:autoimmune thyroiditis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:baseline pregnanediol and pregnanetriol normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:baseline pregnanediol and pregnanetriol normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:brain diseases, metabolic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:brain diseases, metabolic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:c-cell hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:c-cell hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:calcitonin decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:calcitonin decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:carotenemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:carotenemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:catabolic state --- r_associated #0: 20 --> hypoaldostéronisme n1=en:catabolic state | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:central hyperthyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:central hyperthyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:central hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:central hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:central hypothyroidism, borderline --- r_associated #0: 20 --> hypoaldostéronisme n1=en:central hypothyroidism, borderline | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cervical neuroendocrine carcinoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cervical neuroendocrine carcinoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:chemically induced --- r_associated #0: 20 --> hypoaldostéronisme n1=en:chemically induced | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:citrate toxicity --- r_associated #0: 20 --> hypoaldostéronisme n1=en:citrate toxicity | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:compensated hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:compensated hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:complex adrenal endocrine disorder --- r_associated #0: 20 --> hypoaldostéronisme n1=en:complex adrenal endocrine disorder | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:complication aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:complication aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital absence of adrenal gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital absence of adrenal gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital absence of parathyroid gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital absence of parathyroid gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital absence of thymus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital absence of thymus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital adrenal gland hypoplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital adrenal gland hypoplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital adrenal hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital adrenal hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital anomaly of adrenal gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital anomaly of adrenal gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital hyperthyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital hyperthyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital hypoparathyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital hypoparathyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital hypoplasia of thymus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital hypoplasia of thymus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:congenital mesh qualifier --- r_associated #0: 20 --> hypoaldostéronisme n1=en:congenital mesh qualifier | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:corticosteroid deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:corticosteroid deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:corticosterone methyl oxidase type ii deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:corticosterone methyl oxidase type ii deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:corticotropin-releasing hormone deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:corticotropin-releasing hormone deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cortisol deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cortisol deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cortisol insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cortisol insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:crystal arthropathy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:crystal arthropathy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:crystal nephropathy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:crystal nephropathy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cushing disease --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cushing disease | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cushing disease due to increased acth secretion (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cushing disease due to increased acth secretion (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cushing syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cushing syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cushingoid --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cushingoid | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:cushingoid appearance (2 patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:cushingoid appearance (2 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased circulating renin level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased circulating renin level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased fertility --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased fertility | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased fertility in females --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased fertility in females | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased fertility in males --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased fertility in males | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased growth hormone (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased growth hormone (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased growth hormone secretion (1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased growth hormone secretion (1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased secondary sexual characteristics (in a subset of patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased secondary sexual characteristics (in a subset of patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased serum progesterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased serum progesterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased testosterone (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased testosterone (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased testosterone in males --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased testosterone in males | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased testosterone level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased testosterone level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:decreased thyroxine level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:decreased thyroxine level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:defective dht formation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:defective dht formation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:deficient growth hormone response to insulin, arginine, or levodopa --- r_associated #0: 20 --> hypoaldostéronisme n1=en:deficient growth hormone response to insulin, arginine, or levodopa | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delay in secondary sexual characteristics --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delay in secondary sexual characteristics | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed conversion of oral cortisone acetate to plasma cortisol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed conversion of oral cortisone acetate to plasma cortisol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed onset of puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed onset of puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed or incomplete puberty (1 family) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed or incomplete puberty (1 family) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed pubertal development (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed pubertal development (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed puberty (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed puberty (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed secondary sexual characteristics in males --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed secondary sexual characteristics in males | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:delayed testosterone increase at puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:delayed testosterone increase at puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes (in affected males) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes (in affected males) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes (may develop later in life) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes (may develop later in life) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes insipidus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes insipidus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes insipidus (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes insipidus (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus (1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus (1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus, infantile --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus, infantile | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus, insulin-dependent (1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus, insulin-dependent (1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus, insulin-dependent, late onset (uncommon) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus, insulin-dependent, late onset (uncommon) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus, susceptibility to --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus, susceptibility to | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus, type 1 (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus, type 1 (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes mellitus, type 2 (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes mellitus, type 2 (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetes, early-onset (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetes, early-onset (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diabetic ketoacidosis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diabetic ketoacidosis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:diagnosis aspect --- r_associated #0: 20 --> hypoaldostéronisme n1=en:diagnosis aspect | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:disease of adrenal medulla --- r_associated #0: 20 --> hypoaldostéronisme n1=en:disease of adrenal medulla | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:disorder of cortisol-cortisone shuttle --- r_associated #0: 20 --> hypoaldostéronisme n1=en:disorder of cortisol-cortisone shuttle | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:disorders of bilirubin excretion --- r_associated #0: 20 --> hypoaldostéronisme n1=en:disorders of bilirubin excretion | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:drug-induced adrenocortical insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:drug-induced adrenocortical insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:dysfunction adrenal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:dysfunction adrenal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:dysfunction of hypothalamo-pituitary-gonadal axis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:dysfunction of hypothalamo-pituitary-gonadal axis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:dysfunction syndromes, hypothalamic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:dysfunction syndromes, hypothalamic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:early-onset puberty (in 2 of 3 patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:early-onset puberty (in 2 of 3 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:early-onset puberty (menarche about 2 years early) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:early-onset puberty (menarche about 2 years early) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:early-onset type ii diabetes (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:early-onset type ii diabetes (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ectopic hyperthyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ectopic hyperthyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ectopic or absent posterior pituitary --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ectopic or absent posterior pituitary | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ectopic posterior pituitary --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ectopic posterior pituitary | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ectopic thyroid gland (finding) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ectopic thyroid gland (finding) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated 18-hydroxycortisol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated 18-hydroxycortisol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated 18-oxocortisol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated 18-oxocortisol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated aldosterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated aldosterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated androgen metabolite excretion level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated androgen metabolite excretion level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated fasting glucose --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated fasting glucose | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated follicle stimulating hormone (fsh) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated follicle stimulating hormone (fsh) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated follicle-stimulating hormone (fsh) level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated follicle-stimulating hormone (fsh) level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated follicle-stimulating hormone level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated follicle-stimulating hormone level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated growth hormone (gh) levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated growth hormone (gh) levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated igf1 levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated igf1 levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated insulin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated insulin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated luteinizing hormone (lh) level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated luteinizing hormone (lh) level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated prepubertal levels of estradiol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated prepubertal levels of estradiol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated prepubertal levels of testosterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated prepubertal levels of testosterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated serum 17-hydroxyprogesterone level (seen in patients with contiguous gene defect) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated serum adiponectin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated serum adiponectin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated serum estradiol (in male and female patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated serum estradiol (in male and female patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated serum estrone (in male and female patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated serum estrone (in male and female patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated serum follicle-stimulating hormone (in male and female patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated serum follicle-stimulating hormone (in male and female patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated serum luteinizing hormone (in male and female patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated serum luteinizing hormone (in male and female patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated thyroid stimulating hormone (tsh) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated thyroid stimulating hormone (tsh) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:elevated urinary gonadotropins --- r_associated #0: 20 --> hypoaldostéronisme n1=en:elevated urinary gonadotropins | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:embryologic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:embryologic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:endocrine abnormalities, variable, (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:endocrine abnormalities, variable, (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:endocrine dysgenesis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:endocrine dysgenesis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:endocrine features --- r_associated #0: 20 --> hypoaldostéronisme n1=en:endocrine features | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:endocrine glands with iron deposition --- r_associated #0: 20 --> hypoaldostéronisme n1=en:endocrine glands with iron deposition | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:endocrine hypertension --- r_associated #0: 20 --> hypoaldostéronisme n1=en:endocrine hypertension | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:endocrine pancreatic adenoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:endocrine pancreatic adenoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:enhanced insulin sensitivity --- r_associated #0: 20 --> hypoaldostéronisme n1=en:enhanced insulin sensitivity | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:enlarged adrenal gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:enlarged adrenal gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:enlarged thyroid gland (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:enlarged thyroid gland (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:enzyme abnormality (nos) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:enzyme abnormality (nos) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:enzyme induction --- r_associated #0: 20 --> hypoaldostéronisme n1=en:enzyme induction | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:enzyme inhibition disorder --- r_associated #0: 20 --> hypoaldostéronisme n1=en:enzyme inhibition disorder | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:enzymology --- r_associated #0: 20 --> hypoaldostéronisme n1=en:enzymology | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:epidemiologic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:epidemiologic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:episodic asymptomatic severe hypoglycemia in childhood --- r_associated #0: 20 --> hypoaldostéronisme n1=en:episodic asymptomatic severe hypoglycemia in childhood | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:estradiol undetectable --- r_associated #0: 20 --> hypoaldostéronisme n1=en:estradiol undetectable | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ethnologic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ethnologic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:etiology aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:etiology aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:eunuchoid appearance of males --- r_associated #0: 20 --> hypoaldostéronisme n1=en:eunuchoid appearance of males | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:euthyroid (compensated hypothyroidism) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:euthyroid (compensated hypothyroidism) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:euthyroid (finding) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:euthyroid (finding) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:euthyroid multinodular goiter --- r_associated #0: 20 --> hypoaldostéronisme n1=en:euthyroid multinodular goiter | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:euthyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:euthyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:exposure as collected domain --- r_associated #0: 20 --> hypoaldostéronisme n1=en:exposure as collected domain | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:failure of secondary sexual development --- r_associated #0: 20 --> hypoaldostéronisme n1=en:failure of secondary sexual development | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:familial adrenocortical hypoplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:familial adrenocortical hypoplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:fatigue --- r_associated #0: 20 --> hypoaldostéronisme n1=en:fatigue | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:female infertility --- r_associated #0: 20 --> hypoaldostéronisme n1=en:female infertility | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:few and small islets of langerhans --- r_associated #0: 20 --> hypoaldostéronisme n1=en:few and small islets of langerhans | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:follicle stimulating hormone deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:follicle stimulating hormone deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:follicle stimulating hormone, increased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:follicle stimulating hormone, increased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:free thyroxine to free triiodothyronine ratio markedly low --- r_associated #0: 20 --> hypoaldostéronisme n1=en:free thyroxine to free triiodothyronine ratio markedly low | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:functional anorchia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:functional anorchia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:gastrin-producing neuroendocrine tumor --- r_associated #0: 20 --> hypoaldostéronisme n1=en:gastrin-producing neuroendocrine tumor | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:genetic aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:genetic aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:glucagonoma syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:glucagonoma syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:glucocorticoid deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:glucocorticoid deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:glucocorticoid insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:glucocorticoid insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:glucocorticoid resistance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:glucocorticoid resistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:glucose intolerance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:glucose intolerance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:goiter --- r_associated #0: 20 --> hypoaldostéronisme n1=en:goiter | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:goiter may occur --- r_associated #0: 20 --> hypoaldostéronisme n1=en:goiter may occur | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:gonadotrophin increased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:gonadotrophin increased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:gonadotrophin levels low --- r_associated #0: 20 --> hypoaldostéronisme n1=en:gonadotrophin levels low | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:gonadotropin response to exogenous luteinizing hormone releasing hormone (lhrh, in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone deficiency (1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone deficiency (1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone deficiency (2 patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone deficiency (2 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone deficiency (hcs) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone deficiency (hcs) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone deficiency (in 1/4 patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone deficiency (in 1/4 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone deficiency (reported in 1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone deficiency (reported in 1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone deficiency in some individuals --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone deficiency in some individuals | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:growth hormone excess --- r_associated #0: 20 --> hypoaldostéronisme n1=en:growth hormone excess | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hashimoto thyroiditis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hashimoto thyroiditis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hereditary adrenal unresponsiveness to corticotropin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hereditary adrenal unresponsiveness to corticotropin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high absolute level of cortisone metabolites --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high absolute level of cortisone metabolites | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high aldosterone/renin ratio --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high aldosterone/renin ratio | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high follicle-stimulating hormone levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high follicle-stimulating hormone levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high fsh secondary to androgen insensitivity --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high fsh secondary to androgen insensitivity | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high level of cortisone metabolites --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high level of cortisone metabolites | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high luteinizing hormone levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high luteinizing hormone levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high plasma cortisol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high plasma cortisol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high serum leptin levels (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high serum leptin levels (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:high to high-normal cortisol secretion rate --- r_associated #0: 20 --> hypoaldostéronisme n1=en:high to high-normal cortisol secretion rate | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:historical aspects qualifier --- r_associated #0: 20 --> hypoaldostéronisme n1=en:historical aspects qualifier | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperactive renin-angiotensin system --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperactive renin-angiotensin system | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperadrenergic postural hypotension --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperadrenergic postural hypotension | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperaldosteronemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperaldosteronemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperaldosteronemia (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperaldosteronemia (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperaldosteronism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperaldosteronism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperamylasemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperamylasemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperandrogenemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperandrogenemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperbilirubinemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperbilirubinemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypercalcemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypercalcemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypercatabolism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypercatabolism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypercortisolemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypercortisolemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypercortisolism, mild (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypercortisolism, mild (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypercreatinaemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypercreatinaemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypercreatininaemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypercreatininaemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperestrogenism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperestrogenism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperglycemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperglycemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperglycemia (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperglycemia (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperglycemia, insulin-responsive, episodic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperglycemia, insulin-responsive, episodic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypergonadotrophic hypogonadism (in females in adolescence) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypergonadotrophic hypogonadism (in females in adolescence) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypergonadotropic hypogonadism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypergonadotropic hypogonadism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypergonadotropic hypogonadism (hcs) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypergonadotropic hypogonadism (hcs) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypergonadotropic hypogonadism (in a subset of patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypergonadotropic hypogonadism (in a subset of patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypergonadotropic hypogonadism (males) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypergonadotropic hypogonadism (males) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypergonadotropic hypogonadism (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypergonadotropic hypogonadism (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypergonadotropic hypogonadism (reported in 1 female) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypergonadotropic hypogonadism (reported in 1 female) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperinsulinemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperinsulinemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperinsulinemia (in male patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperinsulinemia (in male patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperinsulinemia (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperinsulinemia (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperinsulinemic hypoglycemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperinsulinemic hypoglycemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperinsulinemic hypoglycemia (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperinsulinemic hypoglycemia (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperkalemic mineralocorticoid resistance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperkalemic mineralocorticoid resistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperlipasaemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperlipasaemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypermetabolism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypermetabolism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypernatremia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypernatremia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperoxalaemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperoxalaemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperparathyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperparathyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperphosphatasaemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperphosphatasaemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperprogesteronism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperprogesteronism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperproinsulinemia (asymptomatic in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperproinsulinemia (asymptomatic in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperprolactinemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperprolactinemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperreninemia (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperreninemia (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperreninemic hypoaldosteronism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperreninemic hypoaldosteronism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperreninemic hypoaldosteronism, familial, 2 --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperreninemic hypoaldosteronism, familial, 2 | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypertension --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypertension | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyperthyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyperthyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoadrenalism (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoadrenalism (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoaldosteronism, transient, isolated --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoaldosteronism, transient, isolated | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypocalcemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypocalcemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypocalcemia, mild or severe --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypocalcemia, mild or severe | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypocortisolemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypocortisolemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoglycemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoglycemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoglycemia, fasting --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoglycemia, fasting | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadaism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadaism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadism (1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadism (1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadism (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadism (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadism (reported in 1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadism (reported in 1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadotropic hypergonadism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadotropic hypergonadism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadotropic hypogonadism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadotropic hypogonadism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadotropic hypogonadism (in some females) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadotropic hypogonadism (in some females) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadotropic hypogonadism (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadotropic hypogonadism (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogonadotropic hypogonadism (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogonadotropic hypogonadism (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypogondotropic hypogonadism (1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypogondotropic hypogonadism (1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoinsulinaemia (disorder) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoinsulinaemia (disorder) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypokalemia (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypokalemia (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypomagnesemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypomagnesemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypometabolism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypometabolism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyponatremic mineralocorticoid resistance due to mineralocorticoid receptor defect --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyponatremic mineralocorticoid resistance due to mineralocorticoid receptor defect | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hyponatremic mineralocorticoid resistance due to urinary tract infection --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hyponatremic mineralocorticoid resistance due to urinary tract infection | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoparathyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoparathyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypophosphatemic vitamin d-resistant rickets (in some) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypophosphatemic vitamin d-resistant rickets (in some) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypophyseal agenesis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypophyseal agenesis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypopituitarism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypopituitarism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypopituitarism (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypopituitarism (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoplasia of the thyroid gland in some patients --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoplasia of the thyroid gland in some patients | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoplastic pituitary gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoplastic pituitary gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoplastic thyroid gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoplastic thyroid gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypoprogesteronism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypoprogesteronism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothalamic and/or pituitary defect --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothalamic and/or pituitary defect | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothalamic hypogonadism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothalamic hypogonadism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothalamic insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothalamic insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothalamic-adrenal dysfunction --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothalamic-adrenal dysfunction | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidic goitre --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidic goitre | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (20% of adults) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (20% of adults) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (30% patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (30% patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (if untreated) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (if untreated) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (in 1 of 3 siblings) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (in 1 of 3 siblings) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (in 2/4 patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (in 2/4 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism in subset of patients --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism in subset of patients | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism, autoantibody-positive (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism, autoantibody-positive (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism, autoimmune --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism, autoimmune | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism, congenital (1 patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism, congenital (1 patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:hypothyroidism, nongoitrous --- r_associated #0: 20 --> hypoaldostéronisme n1=en:hypothyroidism, nongoitrous | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:iatrogenic adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:iatrogenic adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:immunology aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:immunology aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:impaired glucose tolerance (in male patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:impaired glucose tolerance (in male patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:impaired glucose tolerance (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:impaired glucose tolerance (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:impaired processing of proopiomelanocortin (pomc, 176830) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:impaired processing of proopiomelanocortin (pomc, 176830) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:impaired temperature regulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:impaired temperature regulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:in blood --- r_associated #0: 20 --> hypoaldostéronisme n1=en:in blood | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:in cerebrospinal fluid --- r_associated #0: 20 --> hypoaldostéronisme n1=en:in cerebrospinal fluid | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:in urine --- r_associated #0: 20 --> hypoaldostéronisme n1=en:in urine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increase in pregnanediol and pregnanetriol after acth stimulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increase in pregnanediol and pregnanetriol after acth stimulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased baseline gonadotropins --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased baseline gonadotropins | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased circulating gonadotropin level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased circulating gonadotropin level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased circulating renin level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased circulating renin level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased cortisol excretion rate --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased cortisol excretion rate | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased gonadotropin levels (in female patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased gonadotropin levels (in female patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased incidence of fibrocalculus pancreatic diabetes (fcpd) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased incidence of fibrocalculus pancreatic diabetes (fcpd) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased prolactin level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased prolactin level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased serum gonadotropins --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased serum gonadotropins | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased serum pth, mild --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased serum pth, mild | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased serum tsh (2 patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased serum tsh (2 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased sweating at early age --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased sweating at early age | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased testosterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased testosterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:increased thyroxine level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:increased thyroxine level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:infertility --- r_associated #0: 20 --> hypoaldostéronisme n1=en:infertility | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insensitivity to growth hormone therapy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insensitivity to growth hormone therapy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin deficiency (may develop later in life) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin deficiency (may develop later in life) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin growth factor i deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin growth factor i deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin growth factor i resistance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin growth factor i resistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin insensitivity --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin insensitivity | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin resistance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin resistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin resistance (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin resistance (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin-dependent but ketosis-resistant diabetes --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin-dependent but ketosis-resistant diabetes | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin-dependent diabetes mellitus (onset in infancy) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin-dependent diabetes mellitus (onset in infancy) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin-like growth factor slightly low --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin-like growth factor slightly low | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin-resistant diabetes mellitus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin-resistant diabetes mellitus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin-resistant diabetes mellitus (onset around puberty) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin-resistant diabetes mellitus (onset around puberty) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin-resistant diabetes mellitus at puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin-resistant diabetes mellitus at puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:insulin-resistant diabetes mellitus in adulthood --- r_associated #0: 20 --> hypoaldostéronisme n1=en:insulin-resistant diabetes mellitus in adulthood | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:intermittent severe hypoglycemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:intermittent severe hypoglycemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:intermittent thrombocytopenia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:intermittent thrombocytopenia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ipsilateral adrenal gland hypoplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ipsilateral adrenal gland hypoplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ipsilateral thyroid gland hypoplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ipsilateral thyroid gland hypoplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:irregular menstruation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:irregular menstruation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:isolated follicle stimulating hormone deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:isolated follicle stimulating hormone deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:isolated glucocorticoid deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:isolated glucocorticoid deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:klinefelter syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:klinefelter syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:lack of growth hormone (gh) response to stimulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:lack of growth hormone (gh) response to stimulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:lack of lh pulsatility --- r_associated #0: 20 --> hypoaldostéronisme n1=en:lack of lh pulsatility | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:lack of secondary sex characteristics --- r_associated #0: 20 --> hypoaldostéronisme n1=en:lack of secondary sex characteristics | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:lack of secondary sexual characteristics (in 1 family) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:lack of secondary sexual characteristics (in 1 family) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:late menarche --- r_associated #0: 20 --> hypoaldostéronisme n1=en:late menarche | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:lh level normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:lh level normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:lingual thyroid --- r_associated #0: 20 --> hypoaldostéronisme n1=en:lingual thyroid | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low acth --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low acth | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low adh (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low adh (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low adrenocorticotropic hormone (acth) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low adrenocorticotropic hormone (acth) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low anti-mullerian hormone (amh) level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low anti-mullerian hormone (amh) level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low c-peptide levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low c-peptide levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low cortols-to-cortolone ratio --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low cortols-to-cortolone ratio | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low estradiol in females --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low estradiol in females | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low estradiol levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low estradiol levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low estradiol levels in females --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low estradiol levels in females | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low estrogen and progesterone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low estrogen and progesterone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low follicle-stimulating hormone (fsh) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low follicle-stimulating hormone (fsh) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low follicle-stimulating hormone levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low follicle-stimulating hormone levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low free-t4 levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low free-t4 levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low gonadotropins (secondary hypogonadism) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low gonadotropins (secondary hypogonadism) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low igf1 and igfbp3 --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low igf1 and igfbp3 | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low inhibin b level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low inhibin b level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low insulin-like growth factor-1 (igf1) concentration --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low insulin-like growth factor-1 (igf1) concentration | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low insulin-like growth factor-i (igf1 147440) levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low insulin-like growth factor-i (igf1 147440) levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low luteinizing hormone (lh) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low luteinizing hormone (lh) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low luteinizing hormone levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low luteinizing hormone levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low or absent growth hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low or absent growth hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low or absent growth hormone (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low or absent growth hormone (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low or absent prolactin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low or absent prolactin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low or absent thyroid-stimulating hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low or absent thyroid-stimulating hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low or normal serum gonadotropins --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low or normal serum gonadotropins | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low prolactin (prl) levels (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low prolactin (prl) levels (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low serum estradiol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low serum estradiol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low serum estradiol levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low serum estradiol levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low serum gonadotropins --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low serum gonadotropins | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low serum leptin levels (in most patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low serum leptin levels (in most patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low serum testosterone in males --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low serum testosterone in males | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low sex hormone-binding globulin levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low sex hormone-binding globulin levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low testosterone in males --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low testosterone in males | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low testosterone levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low testosterone levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low tetrahydrocortisol (thf) plus 5-alpha-thf/tetrahydrocortisone (the) ratio | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low to normal absolute level of cortisol metabolites --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low to normal absolute level of cortisol metabolites | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low to normal level of cortisol metabolites --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low to normal level of cortisol metabolites | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low to normal serum gonadotropins --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low to normal serum gonadotropins | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low to normal serum lh low to normal serum fsh --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low to normal serum lh low to normal serum fsh | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low to undetectable gonadotropin levels --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low to undetectable gonadotropin levels | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low to undetectable insulin levels in the presence of hyperglycemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low to undetectable insulin levels in the presence of hyperglycemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low urinary cortols-to-cortolone ratio --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low urinary cortols-to-cortolone ratio | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low urinary estrogens --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low urinary estrogens | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:low-to-normal serum growth hormone --- r_associated #0: 20 --> hypoaldostéronisme n1=en:low-to-normal serum growth hormone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:luteinizing hormone levels elevated --- r_associated #0: 20 --> hypoaldostéronisme n1=en:luteinizing hormone levels elevated | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:macroamylasemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:macroamylasemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:macronodular adrenal hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:macronodular adrenal hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:marine lenhart syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:marine lenhart syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:marked increase in pregnanetriolone after hcg or acth stimulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:marked increase in pregnanetriolone after hcg or acth stimulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:masculinization at puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:masculinization at puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:maturity-onset diabetes of the young --- r_associated #0: 20 --> hypoaldostéronisme n1=en:maturity-onset diabetes of the young | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:maturity-onset diabetes of the young (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:maturity-onset diabetes of the young (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:medulloadrenal hyperfunction --- r_associated #0: 20 --> hypoaldostéronisme n1=en:medulloadrenal hyperfunction | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:metabolic aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:metabolic aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:metabolic disorder --- r_associated #0: 20 --> hypoaldostéronisme n1=en:metabolic disorder | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:metabolic disorders nec --- r_associated #0: 20 --> hypoaldostéronisme n1=en:metabolic disorders nec | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:metabolic syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:metabolic syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:microbiological --- r_associated #0: 20 --> hypoaldostéronisme n1=en:microbiological | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:mineralocorticoid deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:mineralocorticoid deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:mineralocorticoid insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:mineralocorticoid insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:mineralocorticoid insufficiency (in 15%) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:mineralocorticoid insufficiency (in 15%) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates --- r_associated #0: 20 --> hypoaldostéronisme n1=en:minimal testosterone yielded by progesterone and pregnenolone or their respective 17-alpha-hydroxylates | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:modestly low estradiol --- r_associated #0: 20 --> hypoaldostéronisme n1=en:modestly low estradiol | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:multinodular goiter --- r_associated #0: 20 --> hypoaldostéronisme n1=en:multinodular goiter | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:multiple endocrine neoplasia type 2b --- r_associated #0: 20 --> hypoaldostéronisme n1=en:multiple endocrine neoplasia type 2b | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:multiple hormone resistance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:multiple hormone resistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:myxedema coma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:myxedema coma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:necrosis adrenal cortex --- r_associated #0: 20 --> hypoaldostéronisme n1=en:necrosis adrenal cortex | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:neonatal diabetes mellitus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:neonatal diabetes mellitus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:neonatal hyperbilirubinemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:neonatal hyperbilirubinemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:neonatal hypocalcemia, rare --- r_associated #0: 20 --> hypoaldostéronisme n1=en:neonatal hypocalcemia, rare | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:neonatal hypoglycemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:neonatal hypoglycemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:neonatal hypoparathyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:neonatal hypoparathyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:neonatal insulin-dependent diabetes mellitus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:neonatal insulin-dependent diabetes mellitus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:neurogenic diabetes insipidus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:neurogenic diabetes insipidus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:no adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:no adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:no breast development or menstruation at puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:no breast development or menstruation at puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:no goiter --- r_associated #0: 20 --> hypoaldostéronisme n1=en:no goiter | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:no growth response to exogenous growth hormone (gh, 139250) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:no growth response to exogenous growth hormone (gh, 139250) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:no hormone resistance --- r_associated #0: 20 --> hypoaldostéronisme n1=en:no hormone resistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:no increase in testosterone after hcg or acth stimulation --- r_associated #0: 20 --> hypoaldostéronisme n1=en:no increase in testosterone after hcg or acth stimulation | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:no insulin-dependent diabetes mellitus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:no insulin-dependent diabetes mellitus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:non-neoplastic adrenal gland disorder --- r_associated #0: 20 --> hypoaldostéronisme n1=en:non-neoplastic adrenal gland disorder | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:nonautoimmune insulin-dependent diabetes in second decade of life --- r_associated #0: 20 --> hypoaldostéronisme n1=en:nonautoimmune insulin-dependent diabetes in second decade of life | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal adrenal function --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal adrenal function | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal anterior pituitary function --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal anterior pituitary function | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal female secondary sexual characteristics --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal female secondary sexual characteristics | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal follicle-stimulating hormone (fsh) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal follicle-stimulating hormone (fsh) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal growth hormone response to provocative testing --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal growth hormone response to provocative testing | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal growth hormone studies --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal growth hormone studies | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal luteinizing hormone (lh) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal luteinizing hormone (lh) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal or mildly elevated serum phosphate --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal or mildly elevated serum phosphate | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal pituitary function --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal pituitary function | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal response to exogenously administered insulin --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal response to exogenously administered insulin | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal sized thyroid gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal sized thyroid gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal testosterone level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal testosterone level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal testosterone levels in adulthood --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal testosterone levels in adulthood | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:normal thyroid-stimulating hormone level --- r_associated #0: 20 --> hypoaldostéronisme n1=en:normal thyroid-stimulating hormone level | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:nr5a1 gene --- r_associated #0: 20 --> hypoaldostéronisme n1=en:nr5a1 gene | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:nursing therapy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:nursing therapy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:nutritional and metabolic cardiomyopathy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:nutritional and metabolic cardiomyopathy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:nutritional management --- r_associated #0: 20 --> hypoaldostéronisme n1=en:nutritional management | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:oestradiol decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:oestradiol decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:oestradiol increased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:oestradiol increased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:oligomenorrhea --- r_associated #0: 20 --> hypoaldostéronisme n1=en:oligomenorrhea | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:other adrenal hypofunction --- r_associated #0: 20 --> hypoaldostéronisme n1=en:other adrenal hypofunction | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:other adrenocortical insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:other adrenocortical insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:other adrenocortical overactivity --- r_associated #0: 20 --> hypoaldostéronisme n1=en:other adrenocortical overactivity | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:other and unspecified adrenocortical insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:other and unspecified adrenocortical insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:other specified disorders of adrenal gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:other specified disorders of adrenal gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ovarian failure, premature --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ovarian failure, premature | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:ovarian hyperandrogenemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:ovarian hyperandrogenemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:oxalosis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:oxalosis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pancreatic exocrine deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pancreatic exocrine deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pancreatic insulinoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pancreatic insulinoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pancreatitis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pancreatitis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:panhypopituitarism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:panhypopituitarism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parasitology --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parasitology | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parathyroid gland adenoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parathyroid gland adenoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parathyroid hormone concentration low or low-normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parathyroid hormone concentration low or low-normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parathyroid hormone decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parathyroid hormone decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parathyroid hormone levels low to low-normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parathyroid hormone levels low to low-normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parathyroid hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parathyroid hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parathyroid hyperplasia, benign --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parathyroid hyperplasia, benign | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:parathyroid hypoplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:parathyroid hypoplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:partial deficiency of cytoplasmic dht-binding --- r_associated #0: 20 --> hypoaldostéronisme n1=en:partial deficiency of cytoplasmic dht-binding | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:partial growth hormone deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:partial growth hormone deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:partial or complete serum gonadotropin deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:partial or complete serum gonadotropin deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pathological aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pathological aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:patients have normal pituitary function --- r_associated #0: 20 --> hypoaldostéronisme n1=en:patients have normal pituitary function | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:patients with hypothyroidism have hypoplastic thyroid gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:patients with hypothyroidism have hypoplastic thyroid gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pediatric adverse events terminology --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pediatric adverse events terminology | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pediatric terminology --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pediatric terminology | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pharmacotherapeutic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pharmacotherapeutic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:physiopathological --- r_associated #0: 20 --> hypoaldostéronisme n1=en:physiopathological | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pigmented micronodular adrenal dysplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pigmented micronodular adrenal dysplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pigmented micronodular adrenocortical disease --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pigmented micronodular adrenocortical disease | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary agenesis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary agenesis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary amphophil hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary amphophil hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary anomalies --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary anomalies | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary defects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary defects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary dwarfism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary dwarfism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary gland adenoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary gland adenoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary hormone deficiencies (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary hormone deficiencies (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary hormone deficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary hormone deficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary hypoplasia (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary hypoplasia (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pituitary hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pituitary hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:plasma aldosterone increased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:plasma aldosterone increased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:plasma dihydrotestosterone (dht) is decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:plasma dihydrotestosterone (dht) is decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:plasma testosterone is normal or increased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:plasma testosterone is normal or increased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:polyglandular type i autoimmune syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:polyglandular type i autoimmune syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:poor secondary sexual development (1 family) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:poor secondary sexual development (1 family) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:post-adrenalectomy adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:post-adrenalectomy adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:postprocedural adrenocortical(-medullary) hypofunction --- r_associated #0: 20 --> hypoaldostéronisme n1=en:postprocedural adrenocortical(-medullary) hypofunction | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:postprocedural hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:postprocedural hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:precocious puberty --- r_associated #0: 20 --> hypoaldostéronisme n1=en:precocious puberty | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:precocious puberty (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:precocious puberty (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:precocious puberty in males --- r_associated #0: 20 --> hypoaldostéronisme n1=en:precocious puberty in males | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:precocious puberty with sertoli cell tumor --- r_associated #0: 20 --> hypoaldostéronisme n1=en:precocious puberty with sertoli cell tumor | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pregnanetriolone (ptl) present in urine --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pregnanetriolone (ptl) present in urine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature adrenarche --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature adrenarche | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature menopause --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature menopause | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature menopause (in a subset of patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature menopause (in a subset of patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature ovarian failure (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature ovarian failure (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature ovarian failure in female carriers --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature ovarian failure in female carriers | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature pubarche (in 1 female patient) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature pubarche (in 1 female patient) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature pubertal basal levels of luteinizing hormone (lh) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature pubertal basal levels of luteinizing hormone (lh) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature pubertal stimulated levels of lh --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature pubertal stimulated levels of lh | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:premature thelarche --- r_associated #0: 20 --> hypoaldostéronisme n1=en:premature thelarche | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary adrenal glucocorticoid excess --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary adrenal glucocorticoid excess | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary amenorrhea --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary amenorrhea | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary amenorrhea (in a subset of patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary amenorrhea (in a subset of patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary hyperthyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary hyperthyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary hypogonadism (in 2 male patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary hypogonadism (in 2 male patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary hypothyroidism (reported in 2 patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary hypothyroidism (reported in 2 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:primary testicular failure --- r_associated #0: 20 --> hypoaldostéronisme n1=en:primary testicular failure | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:progesterone undetectable --- r_associated #0: 20 --> hypoaldostéronisme n1=en:progesterone undetectable | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:prolactin level normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:prolactin level normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:prolactin, increased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:prolactin, increased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:prolactin-producing pituitary gland adenoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:prolactin-producing pituitary gland adenoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:prominent body odor --- r_associated #0: 20 --> hypoaldostéronisme n1=en:prominent body odor | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pseudohypoaldosteronism type 1 --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pseudohypoaldosteronism type 1 | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pseudohypoparathyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pseudohypoparathyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:pseudophaeochromocytoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:pseudophaeochromocytoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:psychology qualifier --- r_associated #0: 20 --> hypoaldostéronisme n1=en:psychology qualifier | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:radiotherapeutic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:radiotherapeutic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:reactive hypoglycemia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:reactive hypoglycemia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:refeeding syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:refeeding syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:rehabilitation aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:rehabilitation aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:renal resistance to pth --- r_associated #0: 20 --> hypoaldostéronisme n1=en:renal resistance to pth | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:renal salt wasting --- r_associated #0: 20 --> hypoaldostéronisme n1=en:renal salt wasting | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:roentgenographic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:roentgenographic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:secondary adrenal insufficiency --- r_associated #0: 20 --> hypoaldostéronisme n1=en:secondary adrenal insufficiency | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:secondary amenorrhea --- r_associated #0: 20 --> hypoaldostéronisme n1=en:secondary amenorrhea | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:secondary amenorrhea (in a subset of patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:secondary amenorrhea (in a subset of patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:secondary hyperparathyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:secondary hyperparathyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:secondary sexual characteristics lacking --- r_associated #0: 20 --> hypoaldostéronisme n1=en:secondary sexual characteristics lacking | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:sequential loss of anterior pituitary tropic hormones --- r_associated #0: 20 --> hypoaldostéronisme n1=en:sequential loss of anterior pituitary tropic hormones | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:serum aldosterone elevated --- r_associated #0: 20 --> hypoaldostéronisme n1=en:serum aldosterone elevated | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:serum estrogen decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:serum estrogen decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:serum phosphorus normal or mildly elevated --- r_associated #0: 20 --> hypoaldostéronisme n1=en:serum phosphorus normal or mildly elevated | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:serum prolactin decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:serum prolactin decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:serum testosterone decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:serum testosterone decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:sex-hormone binding globulin markedly elevated --- r_associated #0: 20 --> hypoaldostéronisme n1=en:sex-hormone binding globulin markedly elevated | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:small adrenal gland --- r_associated #0: 20 --> hypoaldostéronisme n1=en:small adrenal gland | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:small to absent parathyroid glands --- r_associated #0: 20 --> hypoaldostéronisme n1=en:small to absent parathyroid glands | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:solitary parathyroid adenomas (rarely multiple) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:solitary parathyroid adenomas (rarely multiple) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:stein-leventhal syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:stein-leventhal syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:steroid withdrawal syndrome --- r_associated #0: 20 --> hypoaldostéronisme n1=en:steroid withdrawal syndrome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:stimulation of the renin/angiotensin/aldosterone axis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:stimulation of the renin/angiotensin/aldosterone axis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:subclinical hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:subclinical hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:subset of patients with ovarioleukodystrophy have primary amenorrhea --- r_associated #0: 20 --> hypoaldostéronisme n1=en:subset of patients with ovarioleukodystrophy have primary amenorrhea | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:suprarenal artery aneurysm --- r_associated #0: 20 --> hypoaldostéronisme n1=en:suprarenal artery aneurysm | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:suprarenal artery embolus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:suprarenal artery embolus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:surgical aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:surgical aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:syndrome of inappropriate antidiuretic hormone secretion --- r_associated #0: 20 --> hypoaldostéronisme n1=en:syndrome of inappropriate antidiuretic hormone secretion | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:taxonomic --- r_associated #0: 20 --> hypoaldostéronisme n1=en:taxonomic | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:tertiary hypothyroidism --- r_associated #0: 20 --> hypoaldostéronisme n1=en:tertiary hypothyroidism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:testicular hypofunction due to defect in adrenocortical hormone synthesis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:testicular hypofunction due to defect in adrenocortical hormone synthesis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:testosterone excess --- r_associated #0: 20 --> hypoaldostéronisme n1=en:testosterone excess | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:therapeutic aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:therapeutic aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thin pituitary stalk --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thin pituitary stalk | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid associated opthalmopathies --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid associated opthalmopathies | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid defect in oxidation and organification of iodide --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid defect in oxidation and organification of iodide | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid disease (less common) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid disease (less common) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid dysplasia/aplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid dysplasia/aplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid failure (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid failure (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid follicular hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid follicular hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid function normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid function normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid gland disorder --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid gland disorder | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid gland follicular adenoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid gland follicular adenoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid gland papillary carcinoma --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid gland papillary carcinoma | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid hormone tests abnormal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid hormone tests abnormal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid hyperplasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid hyperplasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid iodine accumulation defect --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid iodine accumulation defect | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid lymphangiectasia --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid lymphangiectasia | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid stimulating hormone normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid stimulating hormone normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid storm --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid storm | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroid volume 22-66ml (adults) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroid volume 22-66ml (adults) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroiditis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroiditis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyrotoxic cardiomyopathy --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyrotoxic cardiomyopathy | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyrotoxic periodic paralysis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyrotoxic periodic paralysis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroxin binding globulin decreased --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroxin binding globulin decreased | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:thyroxin binding globulin normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:thyroxin binding globulin normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:total and free thyroxine low-normal or subnormal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:total and free thyroxine low-normal or subnormal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:total and free triiodothyronine high-normal or elevated --- r_associated #0: 20 --> hypoaldostéronisme n1=en:total and free triiodothyronine high-normal or elevated | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:total thyroxine to total triiodothyronine ratio markedly low --- r_associated #0: 20 --> hypoaldostéronisme n1=en:total thyroxine to total triiodothyronine ratio markedly low | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:toxic goiter --- r_associated #0: 20 --> hypoaldostéronisme n1=en:toxic goiter | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:toxic nodular goiter --- r_associated #0: 20 --> hypoaldostéronisme n1=en:toxic nodular goiter | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:transient hypothyroidism (in some patients) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:transient hypothyroidism (in some patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:truncal obesity (rare) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:truncal obesity (rare) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:tuberculous addison's disease --- r_associated #0: 20 --> hypoaldostéronisme n1=en:tuberculous addison's disease | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:type 1 diabetes mellitus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:type 1 diabetes mellitus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:type 1 diabetes mellitus developed in some patients --- r_associated #0: 20 --> hypoaldostéronisme n1=en:type 1 diabetes mellitus developed in some patients | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:type 2 diabetes (in some) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:type 2 diabetes (in some) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:type 2 diabetes mellitus --- r_associated #0: 20 --> hypoaldostéronisme n1=en:type 2 diabetes mellitus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:type 2 diabetes mellitus (t2d) --- r_associated #0: 20 --> hypoaldostéronisme n1=en:type 2 diabetes mellitus (t2d) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:type i renal tubular acidosis --- r_associated #0: 20 --> hypoaldostéronisme n1=en:type i renal tubular acidosis | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:undervirilization --- r_associated #0: 20 --> hypoaldostéronisme n1=en:undervirilization | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:urinary 17-hydroxycorticoids normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:urinary 17-hydroxycorticoids normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:urinary 17-oxosteroids normal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:urinary 17-oxosteroids normal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:use of ultrasonography --- r_associated #0: 20 --> hypoaldostéronisme n1=en:use of ultrasonography | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:vasointestinal peptide tumor --- r_associated #0: 20 --> hypoaldostéronisme n1=en:vasointestinal peptide tumor | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:veterinary aspects --- r_associated #0: 20 --> hypoaldostéronisme n1=en:veterinary aspects | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:viruses --- r_associated #0: 20 --> hypoaldostéronisme n1=en:viruses | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 en:waterhouse-friderichsen syndrome, meningococcal --- r_associated #0: 20 --> hypoaldostéronisme n1=en:waterhouse-friderichsen syndrome, meningococcal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 hyperbilirubinémie des nouveau-nés --- r_associated #0: 20 --> hypoaldostéronisme n1=hyperbilirubinémie des nouveau-nés | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20 diabète de la maturité --- r_associated #0: 15 --> hypoaldostéronisme n1=diabète de la maturité | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=15 diabète de type ii --- r_associated #0: 15 --> hypoaldostéronisme n1=diabète de type ii | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=15 diabète sucré de type 2 --- r_associated #0: 15 --> hypoaldostéronisme n1=diabète sucré de type 2 | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=15 diabète sucré type ii --- r_associated #0: 15 --> hypoaldostéronisme n1=diabète sucré type ii | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=15 hyperintense (signal IRM) --- r_associated #0: 15 --> hypoaldostéronisme n1=hyperintense (signal IRM) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=15 infertilité féminine --- r_associated #0: 15 --> hypoaldostéronisme n1=infertilité féminine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=15 Diabète de type II --- r_associated #0: 10 --> hypoaldostéronisme n1=Diabète de type II | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 Insuffisance corticosurrénale --- r_associated #0: 10 --> hypoaldostéronisme n1=Insuffisance corticosurrénale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 acromégalie --- r_associated #0: 10 --> hypoaldostéronisme n1=acromégalie | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 aldostérone --- r_associated #0: 10 --> hypoaldostéronisme n1=aldostérone | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 diabète non insulinodépendant --- r_associated #0: 10 --> hypoaldostéronisme n1=diabète non insulinodépendant | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 diabète sucré non dépendant d'insuline --- r_associated #0: 10 --> hypoaldostéronisme n1=diabète sucré non dépendant d'insuline | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 diabète sucré non insulino dép --- r_associated #0: 10 --> hypoaldostéronisme n1=diabète sucré non insulino dép | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 diabète sucré non insulino-dépendant --- r_associated #0: 10 --> hypoaldostéronisme n1=diabète sucré non insulino-dépendant | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 déficience en hormone de croissance chez certains individus --- r_associated #0: 10 --> hypoaldostéronisme n1=déficience en hormone de croissance chez certains individus | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 déficience en hormone folliculo-stimulante --- r_associated #0: 10 --> hypoaldostéronisme n1=déficience en hormone folliculo-stimulante | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 en:hyperandrogenism --- r_associated #0: 10 --> hypoaldostéronisme n1=en:hyperandrogenism | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 en:hyperintense --- r_associated #0: 10 --> hypoaldostéronisme n1=en:hyperintense | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 fécondité féminine diminuée --- r_associated #0: 10 --> hypoaldostéronisme n1=fécondité féminine diminuée | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hyperaldostéronisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hyperaldostéronisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hyperandrogénie --- r_associated #0: 10 --> hypoaldostéronisme n1=hyperandrogénie | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hyperandrogénisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hyperandrogénisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hyperparathyroïdisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hyperparathyroïdisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hypertension --- r_associated #0: 10 --> hypoaldostéronisme n1=hypertension | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hyperthyroïdisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hyperthyroïdisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hypogonadisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hypogonadisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hypogonadisme hypogonadotrophique --- r_associated #0: 10 --> hypoaldostéronisme n1=hypogonadisme hypogonadotrophique | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hypométabolisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hypométabolisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hypopituitarisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hypopituitarisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hypothyroïdisme --- r_associated #0: 10 --> hypoaldostéronisme n1=hypothyroïdisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 infertilité de la femme --- r_associated #0: 10 --> hypoaldostéronisme n1=infertilité de la femme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 myélolipome --- r_associated #0: 10 --> hypoaldostéronisme n1=myélolipome | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 myélolipomes --- r_associated #0: 10 --> hypoaldostéronisme n1=myélolipomes | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 niveau élevé d'hormone folliculo-stimulante --- r_associated #0: 10 --> hypoaldostéronisme n1=niveau élevé d'hormone folliculo-stimulante | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 panhypopituitarisme --- r_associated #0: 10 --> hypoaldostéronisme n1=panhypopituitarisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 perte séquentielle des hormones trophiques de l'antéhypophyse --- r_associated #0: 10 --> hypoaldostéronisme n1=perte séquentielle des hormones trophiques de l'antéhypophyse | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 pseudohypoparathyroïdisme --- r_associated #0: 10 --> hypoaldostéronisme n1=pseudohypoparathyroïdisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 puberté précoce avec tumeur à cellules de Sertoli --- r_associated #0: 10 --> hypoaldostéronisme n1=puberté précoce avec tumeur à cellules de Sertoli | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 résistance à l'insuline --- r_associated #0: 10 --> hypoaldostéronisme n1=résistance à l'insuline | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 stérilité féminine --- r_associated #0: 10 --> hypoaldostéronisme n1=stérilité féminine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 taux élevés d'hormone folliculostimulante --- r_associated #0: 10 --> hypoaldostéronisme n1=taux élevés d'hormone folliculostimulante | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 taux élevés d'hormone lutéinisante --- r_associated #0: 10 --> hypoaldostéronisme n1=taux élevés d'hormone lutéinisante | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 taxinomique --- r_associated #0: 10 --> hypoaldostéronisme n1=taxinomique | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=10 hypoaldostéronisme hyperréninémique --- r_associated #0: 8 --> hypoaldostéronisme n1=hypoaldostéronisme hyperréninémique | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=8 hyperkaliémie --- r_associated #0: 6 --> hypoaldostéronisme n1=hyperkaliémie | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=6 absence de complexes immuns et de lymphocytes dans le tissu thyroïdien --- r_associated #0: 5 --> hypoaldostéronisme n1=absence de complexes immuns et de lymphocytes dans le tissu thyroïdien | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 chimiorésistance à l'insuline --- r_associated #0: 5 --> hypoaldostéronisme n1=chimiorésistance à l'insuline | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 diabète de type 2 --- r_associated #0: 5 --> hypoaldostéronisme n1=diabète de type 2 | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 diabète sucré de type ii --- r_associated #0: 5 --> hypoaldostéronisme n1=diabète sucré de type ii | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 déficience en hormone adrénocorticotrope --- r_associated #0: 5 --> hypoaldostéronisme n1=déficience en hormone adrénocorticotrope | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 déficience en hormone de libération de la corticotropine --- r_associated #0: 5 --> hypoaldostéronisme n1=déficience en hormone de libération de la corticotropine | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 excès d'hormone de croissance --- r_associated #0: 5 --> hypoaldostéronisme n1=excès d'hormone de croissance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone antidiurétique anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone antidiurétique anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone de croissance humaine anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone de croissance humaine anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone folliculo-stimulante hypophysaire anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone folliculo-stimulante hypophysaire anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone lutéinisante hypophysaire anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone lutéinisante hypophysaire anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone mélanotrope anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone mélanotrope anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone polypeptidique anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone polypeptidique anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone protéique anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone protéique anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone stéroïde anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone stéroïde anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 hormone thyroïdienne anormale --- r_associated #0: 5 --> hypoaldostéronisme n1=hormone thyroïdienne anormale | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 insulino-résistance --- r_associated #0: 5 --> hypoaldostéronisme n1=insulino-résistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 insulinorésistance --- r_associated #0: 5 --> hypoaldostéronisme n1=insulinorésistance | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 pseudo-hypoparathyroïdisme --- r_associated #0: 5 --> hypoaldostéronisme n1=pseudo-hypoparathyroïdisme | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 réponse absente ou faible à la stimulation par l'hormone de libération des gonadotrophines --- r_associated #0: 5 --> hypoaldostéronisme n1=réponse absente ou faible à la stimulation par l'hormone de libération des gonadotrophines | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 testostérone sérique diminuée --- r_associated #0: 5 --> hypoaldostéronisme n1=testostérone sérique diminuée | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5 tumeur à peptide vaso-intestinal --- r_associated #0: 5 --> hypoaldostéronisme n1=tumeur à peptide vaso-intestinal | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=5